Page last updated: 2024-11-10

pterostilbene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators
FloraRankFlora DefinitionFamilyFamily Definition
PterocarpusgenusA plant genus of the family FABACEAE. Members contain TRITERPENES.[MeSH]FabaceaeThe large family of plants characterized by pods. Some are edible and some cause LATHYRISM or FAVISM and other forms of poisoning. Other species yield useful materials like gums from ACACIA and various LECTINS like PHYTOHEMAGGLUTININS from PHASEOLUS. Many of them harbor NITROGEN FIXATION bacteria on their roots. Many but not all species of beans belong to this family.[MeSH]

Cross-References

ID SourceID
PubMed CID5281727
CHEMBL ID83527
CHEBI ID8630
SCHEMBL ID563218
SCHEMBL ID20063
MeSH IDM0280256

Synonyms (90)

Synonym
AC-5283
chebi:8630 ,
pterostilben
4-(3,5-dimethoxystyryl)phenol
CHEMBL83527 ,
LS-14484
BB 0262300
gtpl2681
nsc-613735
nsc613735
tero-still-bean
pteropure
pterostilbene, >=97% (hplc), solid
MEGXP0_000345
NCGC00180691-01
3',5'-dimethoxy-4trans-stilbenol
trans-3,5-dimethoxy-4'-hydroxystilbene
phenol, 4-((1e)-2-(3,5-dimethoxyphenyl)ethenyl)-
pterostilbene, (e)-
4-((e)-2-(3,5-dimethoxyphenyl)ethenyl)phenol
3',5'-dimethoxy-4e-stilbenol
3',5'-dimethoxy-resveratrol
4trans-(2-(3,5-dimethoxyphenyl)ethenyl)phenol
3,5-dimethoxy-4'-hydroxy-trans-stilbene
trans-pterostilbene
pterostilbene ,
537-42-8
MLS000759434
cpd000440694 ,
ACON1_000305
smr000440694
MLS000863581
pterostilbene, pterocarpus marsupium
4-[(e)-2-(3,5-dimethoxyphenyl)ethenyl]phenol
LMPK13090015
HMS2051B10
4''-hydroxy-3,5-dimethoxy stilbene
4-[(e)-2-(3,5-dimethoxy-phenyl)-vinyl]-phenol
e 4-[2-(3,5-dimethoxy-phenyl)-vinyl]-phenol
3,5-dimethoxy-4''-hydroxyl-trans-stilbene
(e)-4-(3,5-dimethoxystyryl)phenol
bdbm50131688
4-[2-(3,5-dimethoxy-phenyl)-vinyl]-phenol
AKOS000277651
4-[(e)-2-(3,5-dimethoxyphenyl)vinyl]phenol;pterostilbene
A829757
P1924
trans-1-(3,5-dimethoxyphenyl)-2-(4-hydroxyphenyl)ethylene
4'-hydroxy-3,5-dimethoxy-trans-stilbene
MLS001424135
phenol, 4-(2-(3,5-dimethoxyphenyl)ethenyl)-, (e)-
26r60s6a5i ,
unii-26r60s6a5i
4-(2-(3,5-dimethoxyphenyl)ethenyl)phenol
4-stilbenol, 3',5'-dimethoxy-, (e)-
3',5'-dimethoxy-4-stilbenol
HMS2270J16
S3937
CCG-101015
(e)-3',5'-dimethoxy-4-stilbenol
(e)-1-hydroxy-4-(3,5-dimethoxy)styrylbenzene
4-[(e)-2-(3,5-dimethoxyphenyl)vinyl]phenol
(e)-4'-hydroxy-3,5-dimethoxystilbene
18259-15-9
SCHEMBL563218
AKOS025310510
NC00265
SCHEMBL20063
W-203025
phenol, 4-[(1e)-2-(3,5-dimethoxyphenyl)ethenyl]-
4-((1e)-2-(3,5-dimethoxyphenyl)ethenyl)phenol
eh-301 component pterostilbene
pterostilbene [who-dd]
HY-N0828
DTXSID9041106 ,
4-[(1e)-2-(3,5-dimethoxyphenyl)ethenyl]phenol
J-523927
phenol,4-[2-(3,5-dmethoxyphenyl)ethenyl]-
CS-W008773
4'-hydroxy-3,5-dimethoxystilbene
4-((e)-2-(3,5-dimethoxyphenyl)vinyl)phenol
dtxcid7021106
4-?[2-?(3,?5-?dimethoxyphenyl)?ethenyl]?-phenol
BCP22675
Q2908011
Z2065715198
AS-13710
AMY24840
phenol, 4-[2-(3,5-dimethoxyphenyl)ethenyl]-
EN300-18388389

Research Excerpts

Overview

Pterostilbene is a stilbenoid chemically related to resveratrol, and has potential for the treatment of cancers. It is a revesterol analog with a long bioavailability and potent anti-inflammatory activity.

ExcerptReferenceRelevance
"Pterostilbene (PT) is a methylated stilbene found in many plant foods."( Gastrointestinal biotransformation and tissue distribution of pterostilbene after long-term dietary administration in mice.
Cai, X; Gao, Z; Li, F; Li, Z; Qi, C; Song, M; Sun, J; Sun, Y; Wang, M; Wang, Q; Wu, X; Xiao, H; Zheng, J, 2022
)
1.68
"Pterostilbene is a stilbenoid chemically related to resveratrol, and has potential for the treatment of cancers."( Chloroquine Potentiates the Anticancer Effect of Pterostilbene on Pancreatic Cancer by Inhibiting Autophagy and Downregulating the RAGE/STAT3 Pathway.
Chen, RJ; Chen, YY; Ho, YS; Lee, YC; Lyu, YJ; Pan, MH; Wang, YJ, 2021
)
1.6
"Pterostilbene is a revesterol analog with a long bioavailability and having potent anti-inflammatory activity in animal studies. "( Pterostilbene exert an anti-arthritic effect by attenuating inflammation, oxidative stress, and alteration of gut microbiota.
Ding, H; Ding, X; Han, J; Li, X; Liu, Y; Rui, Z; Yuan, Y; Zhang, L, 2022
)
3.61
"Pterostilbene (PTS) is a resveratrol analog with neuroprotective activity."( Protective effect of pterostilbene in a streptozotocin-induced mouse model of Alzheimer's disease by targeting monoamine oxidase B.
Chen, L; Li, Q; Li, X; Tian, B, 2022
)
1.76
"Pterostilbene is a methylated derivative of resveratrol. "( Pterostilbene production of tomato transformed with resveratrol synthase and resveratrol O-methyltransferase genes.
Chen, S; Ding, X; Li, J; Ni, L; Pan, Y; Qin, Y; Zhang, X; Zhang, Y, 2022
)
3.61
"Pterostilbene is a trans stilbene compound, which is an effective component of herbaceous plants such as Dalbergia woods and Vaccinium. "( Pterostilbene inhibits melanogenesis, melanocyte dendricity and melanosome transport through cAMP/PKA/CREB pathway.
An, X; Lv, J; Wang, F, 2022
)
3.61
"Pterostilbene is a stilbene flavonoid that occurs naturally in various plants as well as produced by genetic engineering. "( Pterostilbene improves CFA-induced arthritis and peripheral neuropathy through modulation of oxidative stress, inflammatory cytokines and neurotransmitters in Wistar rats.
Abbas, G; Akhtar, MF; Amin, A; Anwar, F; Khan, MI; Saleem, A; Shah, S; Sharif, A; Sohail, MF; Zubair, HM, 2022
)
3.61
"Pterostilbene (PTE) is an active compound extracted from blueberry, and grape, that exhibits many biological effects, such as antiinflammation and antitumor."( Pterostilbene alleviated NAFLD via AMPK/mTOR signaling pathways and autophagy by promoting Nrf2.
Cheng, J; Deng, X; Feng, H; Li, Z; Peng, Y; Shen, B; Wang, Y; Zhang, Q; Zhao, L, 2023
)
3.07
"Pterostilbene is a natural stilbene that has been found to have several pharmacological activities."( Pterostilbene-Mediated Inhibition of Cell Proliferation and Cell Death Induction in Amelanotic and Melanotic Melanoma.
Jesse, K; Kapral, M; Wawszczyk, J, 2023
)
3.07
"Pterostilbene (PTS) is a drug candidate with low water solubility and poor bioavailability. "( The challenge of improving pterostilbene (PTS) solubility for solid and semi-solid dosage forms: The obtention of binary and ternary systems.
Araújo, ASR; Bassani, VL; Benes Raabe, V; Bianchi, SE; de Carvalho Meirelles, G; de Souza Barbosa, F; Delagustin, MG; Dos Santos Lacerda, D; Martiny, S; Pittol, V; Waszczuk, M, 2023
)
2.65
"The pterostilbene skeleton is a promising chemical scaffold that exerts anti-inflammatory, anti-depressant, and anti-tumor effects. "( Discovery of pterostilbene analogs as novel NLRP3 inflammasome inhibitors for potential treatment of DSS-induced colitis in mice.
Chen, L; Deng, L; Gao, T; Liu, X; Ming, Z; Rong, M; Ruan, B; Shi, C; Wang, K; Xu, K; Zhang, X, 2023
)
1.84
"Pterostilbene is a natural chemopreventive compound with various pharmacological properties such as anti-oxidant, anti-proliferative, and anti-inflammatory properties."( Potential Chemopreventive Role of Pterostilbene in Its Modulation of the Apoptosis Pathway.
Basri, DF; Ghazali, AR; Masre, SF; Surien, O, 2023
)
1.91
"Pterostilbene is a demethylated resveratrol derivative with attractive anti-inflammatory, anti-tumor and anti-oxidative stress activities. "( Novel pterostilbene derivatives ameliorate heart failure by reducing oxidative stress and inflammation through regulating Nrf2/NF-κB signaling pathway.
Chen, Y; Duan, Y; Fang, M; Li, Q; Liu, Z; Meng, H; Meng, X; Wang, T; Yang, X; Zhang, Z; Zou, T, 2023
)
2.83
"Pterostilbene is a promising molecule with superior pharmacological activities and pharmacokinetic characteristics compared to its structural analogue resveratrol, which could be used to treat ischemic stroke. "( Illustrate the distribution and metabolic regulatory effects of pterostilbene in cerebral ischemia-reperfusion rat brain by mass spectrometry imaging and spatial metabolomics.
Ban, W; Huang, J; Jiang, X; Jiao, Y; Lv, L; Yang, Z; You, Y, 2024
)
3.12
"Pterostilbene (PTS) is a phenolic compound with diverse pharmacologic activities. "( Pterostilbene Inhibits Adipocyte Conditioned-Medium-Induced Colorectal Cancer Cell Migration through Targeting FABP5-Related Signaling Pathway.
Chen, NC; Ho, CT; Hsiao, YH; Koh, YC; Nagabhushanam, K; Pan, MH, 2019
)
3.4
"Pterostilbene is a naturally occurring dimethylated analogue of resveratrol and has recently been demonstrated to be beneficial against cardiovascular diseases."( Pterostilbene Attenuates Experimental Atherosclerosis through Restoring Catalase-Mediated Redox Balance in Vascular Smooth Muscle Cells.
Chen, J; Chen, YJ; Geng, M; Li, JH; Pan, LL; Sun, J; Wang, W; Wang, YR; Wang, ZX; Wang, ZY; Xu, DC; Xu, ZD, 2019
)
2.68
"Pterostilbene is a useful bioactive compound in preventing type 1 diabetes, insulin resistance and type 2 diabetes in animal models."( Effects of Pterostilbene on Diabetes, Liver Steatosis and Serum Lipids.
Aguirre, L; Fernández-Quintela, A; Gómez-Zorita, S; Milton-Laskíbar, I; Portillo, MP; Xiao, J, 2021
)
1.73
"Pterostilbene is a natural stilbenoid and a dimethylated analogue of resveratrol which is found primarily in blueberries."( Occurrence, Bioavailability, Anti-inflammatory, and Anticancer Effects of Pterostilbene.
Ho, CT; Leland, JV; Lin, WS; Pan, MH, 2020
)
1.51
"The pterostilbene (PT) molecule is a phytoalexin with a reducing effect on reactive oxygen species (ROS) and with a capacity to block lipogenesis. "( Effect of pterostilbene on development, equatorial lipid accumulation and reactive oxygen species production of in vitro-produced bovine embryos.
Álvarez-Gallardo, H; De La Torre-Sánchez, JF; Kjelland, ME; Pérez-Reynozo, S; Romo, S; Sosa, F; Urbán-Duarte, D, 2020
)
1.52
"Pterostilbene is a natural constituent with numerous preventive and therapeutic properties used for treating a wide range of human diseases. "( Development and validation of a specific-stability indicating liquid chromatography method for quantitative analysis of pterostilbene: application in food and pharmaceutical products.
Araújo, ASDR; Bassani, VL; Bianchi, SE; Lacerda, DS; Martiny, S; Pittol, V; Waszczuk, M, 2020
)
2.21
"Pterostilbene is a natural nonflavonoid polyphenolic compound. "( Pterostilbene as a Phytochemical Compound Induces Signaling Pathways Involved in the Apoptosis and Death of Mutant P53-Breast Cancer Cell Lines.
Elsherbini, AM; Sheweita, SA; Sultan, AS, 2021
)
3.51
"Pterostilbene (PTB) is a derivative of resveratrol present in grapes and blueberries. "( Pterostilbene, a Bioactive Component of Blueberries, Alleviates Renal Interstitial Fibrosis by Inhibiting Macrophage-Myofibroblast Transition.
Feng, Y; Fu, P; Guo, F; Liu, J; Ma, L; Mai, H; Xia, Z; Zhang, J; Zhu, G, 2020
)
3.44
"Pterostilbene is a natural 3,5-dimethoxy analog of resveratrol. "( Recent Advances in Synthesis, Bioactivity, and Pharmacokinetics of Pterostilbene, an Important Analog of Resveratrol.
Chen, X; Liu, Y; Lu, J; Yang, Z; You, Y, 2020
)
2.24
"Pterostilbene is a dimethyl ether derivative of resveratrol, less metabolized than its analogue, due to the substitution of two hydroxyl groups with methoxyl groups. "( Activity of Pterostilbene Metabolites against Liver Steatosis in Cultured Hepatocytes.
Krisa, S; Portillo, MP; Trepiana, J, 2020
)
2.38
"Pterostilbene (PTE) is a naturally occurring compound originally isolated from Pterocarpus spp. "( Antibiofilm agent pterostilbene is able to enhance antibiotics action against Staphylococcus epidermidis.
Brázdová, L; Kašparová, P; Lokočová, K; Masák, J; Maťátková, O; Vaňková, E, 2021
)
2.4
"Pterostilbene (PTE) is a natural sterbenoid contained in blueberries that has an antioxidant effect. "( Anti-Stem Cell Property of Pterostilbene in Gastrointestinal Cancer Cells.
Fujii, H; Fujii, K; Fujiwara-Tani, R; Honoki, K; Kido, A; Kishi, S; Kuniyasu, H; Luo, Y; Mori, S; Moriguchi, T; Sasaki, T; Tanaka, Y; Tsukamoto, S, 2020
)
2.3
"Pterostilbene is a natural compound contained in various dietary sources that has received tremendous attention due to its antioxidant properties with promising benefits in cancers and vascular diseases. "( Pterostilbene Improves Stress-Related Behaviors and Partially Reverses Underlying Neuroinflammatory and Hormonal Changes in Stress-Challenged Mice.
Lee, YJ; Park, B, 2021
)
3.51
"Pterostilbene is a potential chemoprevention agent for lung SCC as it has the ability to upregulate the p53/p21 pathway, causing cell cycle arrest."( Chemopreventive effects of pterostilbene through p53 and cell cycle in mouse lung of squamous cell carcinoma model.
Ghazali, AR; Masre, SF; Surien, O, 2021
)
1.64
"Pterostilbene is a natural compound with hepatoprotective potential; however, its implication for alcoholic liver disease was not understood."( Induction of Sestrin2 by pterostilbene suppresses ethanol-triggered hepatocyte senescence by degrading CCN1 via p62-dependent selective autophagy.
Bao, X; Jiang, Y; Jin, H; Lu, C; Wang, X; Xu, W; Zhou, Y, 2023
)
1.93
"Pterostilbene is a stilbenoid and major compound and has diverse biological activities, such as antioxidant, anti-cancer, and anti-inflammatory. "( Anti-adipogenesis mechanism of pterostilbene through the activation of heme oxygenase-1 in 3T3-L1 cells.
Choi, J; Kim, KJ; Koh, EJ; Lee, BY; Seo, YJ, 2017
)
2.18
"Pterostilbene is a naturally occurring analog of resveratrol with many health benefits. "( Autophagy-inducing effect of pterostilbene: A prospective therapeutic/preventive option for skin diseases.
Chen, RJ; Ho, CT; Lee, YH; Li, CY; Wang, BJ; Wang, YJ; Wu, WS; Yeh, YL, 2017
)
2.19
"Pterostilbene is a naturally occurring stilbenoid and phytoalexin found primarily in blueberries that exhibits antioxidant activity and inhibits the growth of various cancer cell types."( Pterostilbene down-regulates hTERT at physiological concentrations in breast cancer cells: Potentially through the inhibition of cMyc.
Daniel, M; Tollefsbol, TO, 2018
)
2.64
"Pterostilbene (PTE) is a natural dimethylated analog of resveratrol, which exerts antioxidative, hypolipidemic and hypoglycemic effects; however, the underlying mechanism is not yet clear. "( Antidiabetic effects of pterostilbene through PI3K/Akt signal pathway in high fat diet and STZ-induced diabetic rats.
Ge, H; Li, W; Li, X; Liu, X; Long, SR; Sun, H; Wang, Y; Xue, Y; Yu, S; Zhang, Y, 2019
)
2.26
"Pterostilbene is a member of the hydroxystilbene family of compounds commonly found in plants such as blueberry and grapes. "( Dehydrodimerization of pterostilbene during electrospray ionization mass spectrometry.
Amad, M; Emwas, AH; Raji, M, 2013
)
2.14
"Pterostilbene is a naturally occurring dimethyl ether analog of resveratrol identified in several plant species. "( Pterostilbene as a potential novel telomerase inhibitor: molecular docking studies and its in vitro evaluation.
Abbagani, S; Porika, M; Prakhya, LJ; Sirisha, K; Thammidala, C; Tippani, R, 2014
)
3.29
"Pterostilbene (PTE) is a stilbene-derived phytoalexin that originates from several natural plant sources. "( In vitro and in vivo activities of pterostilbene against Candida albicans biofilms.
Hu, GH; Huang, TK; Jiang, YY; Li, DD; Mylonakis, E; Wang, Y; Yan, L; Zhao, LX; Zou, Y, 2014
)
2.12
"Pterostilbene is an effective chemopreventive agent against multiple types of cancer cells. "( The novel pterostilbene derivative ANK-199 induces autophagic cell death through regulating PI3 kinase class III/beclin 1/Atg‑related proteins in cisplatin‑resistant CAR human oral cancer cells.
Chen, HP; Chiang, JH; Hsieh, MT; Huang, LJ; Kuo, DH; Kuo, SC; Lu, CC; Wu, TS; Yang, JS, 2014
)
2.25
"Pterostilbene (PTER) is a dimethylated analog of the phenolic phytoalexin, resveratrol, with higher anticancer activity in various tumors. "( Pterostilbene simultaneously induced G0/G1-phase arrest and MAPK-mediated mitochondrial-derived apoptosis in human acute myeloid leukemia cell lines.
Chen, HY; Chien, MH; Chou, YE; Chow, JM; Hsiao, PC; Lee, LM; Lee, WJ; Lin, CH; Tan, P; Yang, SF, 2014
)
3.29
"Pterostilbene is a plant polyphenol compound that is principally found in blueberries. "( Pterostilbene Inhibits Vascular Smooth Muscle Cells Migration and Matrix Metalloproteinase-2 through Modulation of MAPK Pathway.
Hsieh, MJ; Huang, CN; Lin, HC; Peng, CH; Yang, SF, 2015
)
3.3
"Pterostilbene (PTE) is a resveratrol derivative mainly found in blueberries, and it has been shown to inhibit colon carcinogenesis in multiple animal models. "( Identification of pinostilbene as a major colonic metabolite of pterostilbene and its inhibitory effects on colon cancer cells.
Cai, X; Pan, C; Qiu, P; Song, M; Sun, Y; Tang, Z; Wu, X; Xiao, H; Zhang, L; Zheng, J; Zhou, S, 2016
)
2.12
"Pterostilbene (PTE) is a natural anti-oxidant found in blueberries."( Neuroprotective effects of pterostilbene against oxidative stress injury: Involvement of nuclear factor erythroid 2-related factor 2 pathway.
Li, X; Liu, H; Qu, Y; Wang, B; Wang, X; Yang, X; Yang, Y; Yue, L; Zhao, L, 2016
)
1.45
"Pterostilbene (PS) is a well-recognized antioxidant that primarily exists in blueberries, grapevines and heartwood of red sandalwood. "( Promising therapeutic potential of pterostilbene and its mechanistic insight based on preclinical evidence.
Kosuru, R; Prakash, S; Rai, U; Singh, A; Singh, S, 2016
)
2.15
"Pterostilbene (PTE) is a natural compound possessing various biological and pharmacological activities."( Neuroprotective actions of pterostilbene on hypoxic-ischemic brain damage in neonatal rats through upregulation of heme oxygenase-1.
Jiang, Y; Li, D; Song, T; Wang, X; Yang, C; Yang, L, 2016
)
1.45
"Pterostilbene (PTE), is a natural analog of resveratrol, possessing diverse pharmacological activities."( Pterostilbene inhibits hepatocellular carcinoma through p53/SOD2/ROS-mediated mitochondrial apoptosis.
Guo, L; Tan, K; Wang, H; Zhang, X, 2016
)
2.6
"Pterostilbene (PTE) is a natural dimethylated analog of resveratrol, which has anti-oxidant, anti-inflammatory and anti-tumor properties."( Pterostilbene Inhibits Human Multiple Myeloma Cells via ERK1/2 and JNK Pathway In Vitro and In Vivo.
Chang, G; Chen, G; Dai, B; Hu, L; Li, B; Shi, J; Sun, X; Tao, Y; Wei, R; Wu, H; Xie, B; Xu, Z; Yang, G; Zhang, Y; Zhu, W, 2016
)
2.6
"Pterostilbene is a resveratrol dimethylether derivative which shows higher bioavailability."( Effects of pterostilbene in brown adipose tissue from obese rats.
Aguirre, L; Bujanda, L; Hijona, E; Milton-Laskibar, I; Portillo, MP; Rimando, AM, 2016
)
1.55
"Pterostilbene (PTE) is a natural, dimethylated analog of resveratrol with higher bioavailability."( Pterostilbene exerts antitumor activity against human osteosarcoma cells by inhibiting the JAK2/STAT3 signaling pathway.
Cao, X; Feng, D; Li, X; Liu, Y; Luo, Z; Lv, C; Wang, L; Wu, Y; Yang, M, 2013
)
2.55

Effects

Pterostilbene has been shown to reduce weight gain, liver fat, plasma cholesterol, adiposity, inflammatory biomarkers, blood glucose, and other physiological characteristics of metabolic diseases. The drug has notable cardioprotective effects, but its main mechanisms are not fully understood.

ExcerptReferenceRelevance
"Pterostilbene has an inhibitory effect on leptin-stimulated breast cancer in vitro through reduction of cell proliferation and JAK/STAT3 signaling, a critical regulatory component of tumorigenesis in obesity-related breast cancer."( The antiproliferative effects of pterostilbene on breast cancer in vitro are via inhibition of constitutive and leptin-induced Janus kinase/signal transducer and activator of transcription activation.
McCormack, D; McDonald, D; McFadden, D; Schneider, J, 2011
)
2.09
"Pterostilbene (PTS) has favorable hepatoprotective activities."( Pterostilbene attenuates RIPK3-dependent hepatocyte necroptosis in alcoholic liver disease via SIRT2-mediated NFATc4 deacetylation.
Jiang, Y; Lu, C; Shao, Y; Wang, X; Wu, R; Zhou, Y, 2021
)
2.79
"Pterostilbene (PS) has been reported as an effective antioxidant and anti-inflammatory agent in preclinical IBD models."( Oral Delivery of Pterostilbene by L-Arginine-Mediated "Nano-Bomb" Carrier for the Treatment of Ulcerative Colitis.
Cao, Y; Li, R; Ma, Y; Wei, W; Yan, X; Yang, M; Zhang, M; Zhang, Y, 2022
)
1.78
"Pterostilbene has been reported to display lipid-lowing activity and participate in many kidney diseases."( Pterostilbene, a Resveratrol Derivative, Improves Ectopic Lipid Deposition in the Kidneys of Mice Induced by a High-Fat Diet.
Geng, J; Gu, W; Guan, Y; Hou, X; Li, X; Song, G; Wang, C; Wang, X; Yang, L; Zheng, K, 2022
)
2.89
"Pterostilbene has notable cardioprotective effects, but its main mechanisms are not fully understood."( JAK2/STAT3 pathway mediates beneficial effects of pterostilbene on cardiac contractile and electrical function in the setting of myocardial reperfusion injury.
Li, S; Wang, H; Zhou, Y, 2022
)
1.7
"Pterostilbene (PT) has been demonstrated to mitigate ER stress and protect against intestinal disorders."( Pterostilbene Prevents Tunicamycin-Induced Intestinal Barrier Damage by Targeting Endoplasmic Reticulum Stress, Oxidative Stress, Autophagy, and Gut Microbiota.
Chen, Y; Ji, S; Jia, P; Li, Y; Wang, T; Zhang, H, 2022
)
2.89
"Pterostilbene has been found to be an active scaffold with anti-breast cancer (BC) action. "( Synthesis, In Vitro, and In Vivo Investigations of Pterostilbene-Tethered Analogues as Anti-Breast Cancer Candidates.
Chen, J; Feng, X; Hu, C; Li, G; Li, J; Wang, W; Yu, X; Yuan, S; Zhang, W, 2023
)
2.6
"Pterostilbene (PTE) has inhibitory effect on a wide array of tumors. "( Pterostilbene Inhibits Human Renal Cell Carcinoma Cells Growth and Induces DNA Damage.
Li, J; Liu, J; Luo, Q; Ye, D; Zhao, Y, 2020
)
3.44
"Pterostilbene has been shown to reduce weight gain, liver fat, plasma cholesterol, adiposity, inflammatory biomarkers, blood glucose, and other physiological characteristics of metabolic diseases in animal models."( Chemistry of Pterostilbene and Its Metabolic Effects.
Kim, H; Seo, KH; Yokoyama, W, 2020
)
1.65
"Pterostilbene (PTE) has remarkable pharmacological activities, including anticancer and neuroprotection."( The Antithrombotic Agent Pterostilbene Interferes with Integrin α
Bhavan, PS; Chen, TY; Hou, SM; Hsia, CH; Hsia, CW; Huang, WC; Lin, KC; Sheu, JR, 2021
)
1.65
"Pterostilbene has been reported as a potential drug to inhibit oxidative stress and inflammation. "( Pterostilbene inhibits inflammation and ROS production in chondrocytes by activating Nrf2 pathway.
Lin, JP; Liu, HX; Sheng, SR; Xu, H; Xue, EX; Zhang, Y; Zhou, YL, 2017
)
3.34
"Pterostilbene has also been reported to modulate the expression of various oncogenic and tumor suppressor microRNAs in cancer cells."( Regulation of signal transduction cascades by Pterostilbenes in different cancers: Is it a death knell for oncogenic pathways.
Alaaeddine, N; Aras, A; Attar, R; Butt, G; Farooqi, AA; Ozbey, U; Ozcelik, B; Qadir, MI; Tabassum, S, 2017
)
1.43
"Pterostilbene has anti-fibrotic effect."( Pterostilbene alleviates fructose-induced renal fibrosis by suppressing TGF-β1/TGF-β type I receptor/Smads signaling in proximal tubular epithelial cells.
Chen, TY; Gu, TT; Kong, LD; Li, TS; Sun, Y; Yang, YZ; Zhang, DM; Zhao, XJ, 2019
)
2.68
"Pterostilbene (PTE) has shown anti-invasion activity, and thus, we investigated whether PTE inhibited the epithelial-mesenchymal transition (EMT) in TNBC."( The anti-tumor efficiency of pterostilbene is promoted with a combined treatment of Fas signaling or autophagy inhibitors in triple negative breast cancer cells.
Chen, WC; Ho, CT; Hsu, KY; Hung, CM; Kuo, SC; Lin, YC; Way, TD; Yang, NS, 2014
)
1.41
"Pterostilbene (PTB) has been suggested to protect against myocardial ischemia/reperfusion (MI/R) injury. "( Protective Effects of Pterostilbene Against Myocardial Ischemia/Reperfusion Injury in Rats.
Huang, K; Lu, S; Wu, M; Zhang, S; Zhong, J, 2017
)
2.21
"Pterostilbene has an inhibitory effect on leptin-stimulated breast cancer in vitro through reduction of cell proliferation and JAK/STAT3 signaling, a critical regulatory component of tumorigenesis in obesity-related breast cancer."( The antiproliferative effects of pterostilbene on breast cancer in vitro are via inhibition of constitutive and leptin-induced Janus kinase/signal transducer and activator of transcription activation.
McCormack, D; McDonald, D; McFadden, D; Schneider, J, 2011
)
2.09
"Pterostilbene has also been shown to be effective as an inducer of antioxidant capacity in multiple cancer cell lines that may facilitate its function as an anticarcinogenic compound."( Pterostilbene and cancer: current review.
McCormack, D; McFadden, D, 2012
)
2.54

Actions

Pterostilbene can suppress hRECs over proliferation, decrease TNF-α and IL-1β, inhibit NF-κB protein expression, reduce ROS production, and increase SOD activity markedly compared with high glucose group. It was found to inhibit the cell proliferating factors like Akt, Bcl-2 and induced the mitochondrial apoptotic signals like Bax.

ExcerptReferenceRelevance
"Pterostilbene mainly plays a role by inhibiting cAMP/PKA/CREB signal pathway."( Pterostilbene inhibits melanogenesis, melanocyte dendricity and melanosome transport through cAMP/PKA/CREB pathway.
An, X; Lv, J; Wang, F, 2022
)
2.89
"Pterostilbene can suppress hRECs over proliferation, decrease TNF-α and IL-1β, inhibit NF-κB protein expression, reduce ROS production, and increase SOD activity markedly compared with high glucose group (P < 0.05)."( Pterostilbene impact on retinal endothelial cells under high glucose environment.
Rong, H; Shen, H, 2015
)
2.58
"Pterostilbene was found to inhibit the cell proliferating factors like Akt, Bcl-2 and induced the mitochondrial apoptotic signals like Bax, and the series of caspases."( In vitro evaluation of the cytotoxic, anti-proliferative and anti-oxidant properties of pterostilbene isolated from Pterocarpus marsupium.
Chakraborty, A; Ghosh, K; Gupta, N; Roy, P, 2010
)
1.3
"Pterostilbene significantly increase MnSOD activity in MDA-MB-231 cells."( Pterostilbene induces mitochondrially derived apoptosis in breast cancer cells in vitro.
McCormack, D; McDonald, D; McFadden, D; Moon, D, 2013
)
2.55
"Pterostilbene promotes cancer cell death via a mechanism involving lysosomal membrane permeabilization."( Pterostilbene-induced tumor cytotoxicity: a lysosomal membrane permeabilization-dependent mechanism.
Estrela, JM; Jäättela, M; Mena, S; Ortega, AL; Ponsoda, X; Rodríguez, ML, 2012
)
2.54

Treatment

Pterostilbene treatment to fructose-fed diabetic rats significantly decreased HOMA-IR (p<0.001) values. At concentrations that demonstrated over 75% cell viability, the drug significantly increased gene expression of ACO, CPT-1, and PPAR-α.

ExcerptReferenceRelevance
"Pterostilbene treatment significantly (p < 0.0001) reduced TNF-α and IL-6 levels."( Pterostilbene improves CFA-induced arthritis and peripheral neuropathy through modulation of oxidative stress, inflammatory cytokines and neurotransmitters in Wistar rats.
Abbas, G; Akhtar, MF; Amin, A; Anwar, F; Khan, MI; Saleem, A; Shah, S; Sharif, A; Sohail, MF; Zubair, HM, 2022
)
2.89
"Pterostilbene treatment to fructose-fed diabetic rats significantly decreased HOMA-IR (p<0.001) values."( Pterostilbene ameliorates insulin sensitivity, glycemic control and oxidative stress in fructose-fed diabetic rats.
Kosuru, R; Singh, S, 2017
)
2.62
"Pterostilbene treatment, at concentrations that demonstrated over 75% cell viability (20 μM, 50 μM), significantly increased gene expression of ACO, CPT-1, and PPAR-α."( AMPK activation by pterostilbene contributes to suppression of hepatic gluconeogenic gene expression and glucose production in H4IIE cells.
Mathews, ST; Ren, G; Rimando, AM, 2018
)
1.53
"Pterostilbene-treated cells showed evident signs of DNA ladder formation and the effect increased with increasing concentrations of the drug."( Pterostilbene (3',5'-dimethoxy-resveratrol) exerts potent antitumor effects in HeLa human cervical cancer cells via disruption of mitochondrial membrane potential, apoptosis induction and targeting m-TOR/PI3K/Akt signalling pathway.
Da, LH; Hong Bin, W; Jing, B; Xue, Y,
)
2.3
"Pterostilbene treatment increased caspase-3/7 activity and apoptosis in both cell lines."( Pterostilbene inhibits breast cancer in vitro through mitochondrial depolarization and induction of caspase-dependent apoptosis.
Alosi, JA; McDonald, DE; McFadden, DW; Privette, AR; Schneider, JS, 2010
)
2.52
"Pterostilbene treatment inhibits the growth of breast cancer in vitro through caspase-dependent apoptosis. "( Pterostilbene inhibits breast cancer in vitro through mitochondrial depolarization and induction of caspase-dependent apoptosis.
Alosi, JA; McDonald, DE; McFadden, DW; Privette, AR; Schneider, JS, 2010
)
3.25
"Pterostilbene treatment also inhibited leptin-induced cell proliferation."( The antiproliferative effects of pterostilbene on breast cancer in vitro are via inhibition of constitutive and leptin-induced Janus kinase/signal transducer and activator of transcription activation.
McCormack, D; McDonald, D; McFadden, D; Schneider, J, 2011
)
1.37
"Pterostilbene-treated cells were analyzed for cytochrome C, Smac/DIABLO, manganese superoxide dismutase (MnSOD)/antioxidant activity, and STAT3 phosphorylation using ELISA."( Genomic analysis of pterostilbene predicts its antiproliferative effects against pancreatic cancer in vitro and in vivo.
Hanson, J; Mannal, P; McCormack, DE; McDonald, D; McFadden, D; Tighe, S, 2012
)
1.42
"Pterostilbene treatment inhibited TNF-α-induced secretion of lipase (P<0.01 and P<0.001), IL-1β (P<0.05), and IL-6 (P<0.05 and P<0.01)."( Pterostilbene ameliorates tumor necrosis factor alpha-induced pancreatitis in vitro.
McCormack, D; McDonald, D; McFadden, D, 2012
)
2.54
"Treatment with pterostilbene also ameliorated the CFA-induced pannus formation, cartilage damage and synovial hyperplasia in the arthritic rat paws."( Pterostilbene improves CFA-induced arthritis and peripheral neuropathy through modulation of oxidative stress, inflammatory cytokines and neurotransmitters in Wistar rats.
Abbas, G; Akhtar, MF; Amin, A; Anwar, F; Khan, MI; Saleem, A; Shah, S; Sharif, A; Sohail, MF; Zubair, HM, 2022
)
2.5
"Treatment with pterostilbene resulted in the reduction of LPS-induced nuclear translocation of the nuclear factor-kappaB (NFkappaB) subunit and the dependent transcriptional activity of NFkappaB by blocking phosphorylation of inhibitor kappaB (IkappaB)alpha and p65 and subsequent degradation of IkappaB alpha."( Pterostilbene suppressed lipopolysaccharide-induced up-expression of iNOS and COX-2 in murine macrophages.
Badmaev, V; Chang, YH; Ho, CT; Ho, SY; Lai, CS; Pan, MH; Tsai, ML, 2008
)
2.13
"Pretreatment with pterostilbene prevented the inhibition of GJIC via the down-regulation of connexin43 phosphorylation by the inactivation of ERK1/2 and p38 MAP kinase."( Pterostilbene from Vitis coignetiae protect H2O2-induced inhibition of gap junctional intercellular communication in rat liver cell line.
Ahn, J; Ha, TY; Kim, HK; Kim, JS; Kim, S, 2009
)
2.12
"Treatment with pterostilbene resulted in the induction of apoptosis in mouse colon."( Pterostilbene inhibits colorectal aberrant crypt foci (ACF) and colon carcinogenesis via suppression of multiple signal transduction pathways in azoxymethane-treated mice.
Badmaev, V; Cheng, AC; Chiou, YS; Ho, CT; Lai, WM; Pan, MH; Tsai, ML; Wang, YJ, 2010
)
2.14
"Pretreatment with pterostilbene has resulted in the reduction of 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced nuclear translocation of the nuclear factor-κB (NFκB) subunits."( Pterostilbene, a natural analogue of resveratrol, potently inhibits 7,12-dimethylbenz[a]anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA)-induced mouse skin carcinogenesis.
Chang, YH; Chen, WJ; Ho, CT; Lai, CS; Pan, MH; Tsai, ML, 2012
)
2.15
"Pretreatment with pterostilbene at 50 or 250 mg/kg significantly reduced tumor multiplicity by 26 and 49%, respectively."( Chemopreventive effects of pterostilbene on urethane-induced lung carcinogenesis in mice via the inhibition of EGFR-mediated pathways and the induction of apoptosis and autophagy.
Chen, RJ; Ho, CT; Ho, YS; Pan, MH; Tsai, SJ; Wang, YJ; Wu, CH, 2012
)
1
"Treatment with pterostilbene resulted in a transient accumulation of cells in the G(0)/G(1)-cell cycle phase followed by the S-phase arrest."( Pterostilbene induces cell cycle arrest and apoptosis in MOLT4 human leukemia cells.
Boguslawski, W; Jozwik, A; Kaszubowska, L; Kowalczyk, A; Siedlecka-Kroplewska, K, 2012
)
2.16
"Treatment with pterostilbene resulted in a significant reduction of glycosylated hemoglobin and an increase in total hemoglobin level."( Effect of pterostilbene on hepatic key enzymes of glucose metabolism in streptozotocin- and nicotinamide-induced diabetic rats.
Pari, L; Satheesh, MA, 2006
)
1.08

Toxicity

ExcerptReferenceRelevance
" Following a 24-hour incubation of a toxic concentration of CEES (1000 μmol L-1), we used the MTT [3-(4,5-dimethylthiazol- 2-yl)-2,5-diphenyltetrazolium bromide] test to analyse cell viability."( Ebselen analogues reduce 2-chloroethyl ethyl sulphide toxicity in A-431 cells.
Billack, B; Pietka-Ottlik, M; Pino, MA, 2013
)
0.39
" Furthermore, these toxic effects have not been fully explored."( Modulation of Innate Immune Toxicity by Silver Nanoparticle Exposure and the Preventive Effects of Pterostilbene.
Chen, RJ; Chen, YY; Huang, CC; Lee, YH; Pranata, R; Wang, YJ; Wu, YH, 2021
)
0.84
" In the current study, it has been demonstrated that PTS could enhance the level of glyoxalase 1 (GLO-1) and elevate glutathione (GSH) content to active the glyoxalase system, resulting in elimination of the toxic MGO as well as advanced glycation end products (AGEs) in HUVECs."( Pterostilbene prevents methylglyoxal-induced cytotoxicity in endothelial cells by regulating glyoxalase, oxidative stress and apoptosis.
Chen, ZQ; Gu, WT; Nie, H; Tang, D; Wang, SM; Xiao, W; Xu, SH; Xu, YH; Zhang, LY; Zhang, ZT, 2021
)
2.06

Pharmacokinetics

ExcerptReferenceRelevance
" This simple HPLC method was subsequently applied in a pharmacokinetic study carried out in Sprague-Dawley rats."( Determination of pterostilbene in rat plasma by a simple HPLC-UV method and its application in pre-clinical pharmacokinetic study.
Ho, PC; Lin, HS; Yue, BD, 2009
)
0.69
" Noncompartmental analysis was used to derive pharmacokinetic parameters."( Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats.
Huang, Z; Kapetanovic, IM; McCormick, DL; Muzzio, M; Thompson, TN, 2011
)
0.58
"8 mL/min/kg) and moderate terminal elimination half-life (t(1/2λz) = 93."( Pharmacokinetics of pterostilbene in Sprague-Dawley rats: the impacts of aqueous solubility, fasting, dose escalation, and dosing route on bioavailability.
Ho, PC; Lin, HS; Yeo, SC, 2013
)
0.71
" Pharmacokinetic studies so far have focused on plasma levels, while Pt distribution in tissues is most relevant for biological action."( Pharmacokinetics and tissue distribution of pterostilbene in the rat.
Azzolini, M; Biasutto, L; La Spina, M; Mattarei, A; Paradisi, C; Zoratti, M, 2014
)
0.66
" The analytical method was successfully applied to a pharmacokinetic study of the multi-components after oral administration of Sanjie Zhentong Capsule in rats."( Simultaneous determination of ten bioactive constituents of Sanjie Zhentong Capsule in rat plasma by ultra-high-performance liquid chromatography tandem mass spectrometry and its application to a pharmacokinetic study.
Hu, JH; Huang, W; Li, D; Li, J; Pan, Y; Wang, Y; Wang, ZZ; Xiao, W, 2017
)
0.46

Compound-Compound Interactions

ExcerptReferenceRelevance
" In addition, we aimed to explore differences in drug-drug interactions across multiple GBM-derived cell cultures and predict such differences by use of transcriptional biomarkers."( Comparative drug pair screening across multiple glioblastoma cell lines reveals novel drug-drug interactions.
Baskaran, S; Forsberg Nilsson, K; Gerlee, P; Häggblad, M; Hansson, C; Karlsson-Lindahl, L; Kling, T; Lundgren, B; Martens, U; Monsefi, N; Nelander, S; Olsson, M; Schmidt, L; Uhrbom, L; Westermark, B, 2013
)
0.39
"We performed a screen in which we quantified drug-drug interactions for 465 drug pairs in each of the 5 GBM cell lines U87MG, U343MG, U373MG, A172, and T98G."( Comparative drug pair screening across multiple glioblastoma cell lines reveals novel drug-drug interactions.
Baskaran, S; Forsberg Nilsson, K; Gerlee, P; Häggblad, M; Hansson, C; Karlsson-Lindahl, L; Kling, T; Lundgren, B; Martens, U; Monsefi, N; Nelander, S; Olsson, M; Schmidt, L; Uhrbom, L; Westermark, B, 2013
)
0.39
"The antibacterial activity of pterostilbene in combination with gentamicin against six strains of Gram-positive and Gram-negative bacteria were investigated."( Bactericidal Effect of Pterostilbene Alone and in Combination with Gentamicin against Human Pathogenic Bacteria.
Basri, DF; Ghazali, AR; Lee, WX, 2017
)
1.05

Bioavailability

Pterostilbene exhibits much greater bioavailability compared with other stil bene compounds. Other natural stilbenes derived from resveratrol display higher oral bioavailability and bioactivity than the parent compound, but are far less abundant in natural sources.

ExcerptReferenceRelevance
"5 mL/min/kg, respectively, while its absolute oral bioavailability was 12."( Determination of pterostilbene in rat plasma by a simple HPLC-UV method and its application in pre-clinical pharmacokinetic study.
Ho, PC; Lin, HS; Yue, BD, 2009
)
0.69
"When administered orally, pterostilbene demonstrates greater bioavailability and total plasma levels of both the parent compound and metabolites than does resveratrol."( Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats.
Huang, Z; Kapetanovic, IM; McCormick, DL; Muzzio, M; Thompson, TN, 2011
)
0.88
" Overall, the results demonstrated that pterostilbene had more potent inhibitory effects on colon cancer cells than resveratrol, which may be associated with the superior bioavailability of pterostilbene to resveratrol."( Inhibitory effects of resveratrol and pterostilbene on human colon cancer cells: a side-by-side comparison.
Decker, EA; Dong, P; McClements, DJ; Nutakul, W; Qiu, P; Sobers, HS; Xiao, H, 2011
)
0.91
" Additionally, preliminary studies show that pterostilbene exhibits much greater bioavailability compared with other stilbene compounds; however the exact pharmacologic mechanism of pterostilbene and its effects in humans are still under investigation."( Pterostilbene and cancer: current review.
McCormack, D; McFadden, D, 2012
)
2.08
" This study aimed to investigate the impacts of aqueous solubility, fasting, dose escalation, and dosing route on its bioavailability in Sprague-Dawley rats."( Pharmacokinetics of pterostilbene in Sprague-Dawley rats: the impacts of aqueous solubility, fasting, dose escalation, and dosing route on bioavailability.
Ho, PC; Lin, HS; Yeo, SC, 2013
)
0.71
" When given in oral suspension (15 mg/kg), PTS had relatively low bioavailability (F = 15."( Pharmacokinetics of pterostilbene in Sprague-Dawley rats: the impacts of aqueous solubility, fasting, dose escalation, and dosing route on bioavailability.
Ho, PC; Lin, HS; Yeo, SC, 2013
)
0.71
"Aqueous solubility was identified as a barrier to its oral bioavailability while solubilizing PTS with HP-β-CD substantially increased its bioavailability; dose manipulation was a practical strategy to enhance its bioavailability and systemic exposure; and its delivery through oral mucosa was feasible."( Pharmacokinetics of pterostilbene in Sprague-Dawley rats: the impacts of aqueous solubility, fasting, dose escalation, and dosing route on bioavailability.
Ho, PC; Lin, HS; Yeo, SC, 2013
)
0.71
" It has increased bioavailability in comparison to other stilbene compounds, which may enhance its dietary benefit and possibly contribute to a valuable clinical effect."( A review of pterostilbene antioxidant activity and disease modification.
McCormack, D; McFadden, D, 2013
)
0.77
" However, the higher in vivo bioavailability of pterostilbene represents a fundamental advantage."( Pterostilbene: Biomedical applications.
Asensi, M; Estrela, JM; Mena, S; Ortega, A; Rodriguez, ML,
)
1.83
"Pterostilbene, a methoxylated analog of Resveratrol, is gradually gaining more importance as a therapeutic drug owing to its higher lipophilicity, bioavailability and biological activity than Resveratrol."( Protective effect of Pterostilbene against free radical mediated oxidative damage.
Acharya, JD; Ghaskadbi, SS, 2013
)
2.15
" Oral administration (same dose) resulted in moderate Pt bioavailability (∼35%) and in an increased abundance of Pt-S in blood (AUC(Pt)/AUC(Pt-S) ∼0."( Pharmacokinetics and tissue distribution of pterostilbene in the rat.
Azzolini, M; Biasutto, L; La Spina, M; Mattarei, A; Paradisi, C; Zoratti, M, 2014
)
0.66
" The validated method was applied to the study of bioavailability and tissue distribution of PTS in normal and Lewis lung carcinoma (LLC) bearing mice."( UPLC-MS method for quantification of pterostilbene and its application to comparative study of bioavailability and tissue distribution in normal and Lewis lung carcinoma bearing mice.
Chen, B; Deng, L; Deng, Y; Li, Y; Zhang, X, 2015
)
0.69
" Other natural stilbenes derived from resveratrol such as pterostilbene or piceatannol, display higher oral bioavailability and bioactivity than the parent compound, but are far less abundant in natural sources."( Production of highly bioactive resveratrol analogues pterostilbene and piceatannol in metabolically engineered grapevine cell cultures.
Bru-Martínez, R; Cusidó, RM; Martínez-Márquez, A; Morante-Carriel, JA; Palazon, J; Ramírez-Estrada, K, 2016
)
0.93
"Pterostilbene, an analog of resveratrol increasing bioavailability has shown to offer antioxidant and anticancer properties in vitro and in vivo."( Pterostilbene induces apoptosis through caspase activation in ovarian cancer cells.
Chen, Y; Dong, J; Guo, H, 2016
)
3.32
" However, the greater in vivo bioavailability of PS, as compared to resveratrol, is an added advantage for its efficacy."( Promising therapeutic potential of pterostilbene and its mechanistic insight based on preclinical evidence.
Kosuru, R; Prakash, S; Rai, U; Singh, A; Singh, S, 2016
)
0.71
"Pterostilbene, a structural analog of resveratrol, has higher oral bioavailability and bioactivity than that of the parent compound; but is far less abundant in natural sources."( De novo biosynthesis of pterostilbene in an Escherichia coli strain using a new resveratrol O-methyltransferase from Arabidopsis.
Heo, KT; Hong, YS; Kang, SY, 2017
)
2.2
"The biomedical effects of the natural phenol pterostilbene are of great interest but its bioavailability is negatively affected by the phenolic group in position 4' which is an ideal target for the conjugative enzymes of phase II metabolism."( New natural amino acid-bearing prodrugs boost pterostilbene's oral pharmacokinetic and distribution profile.
Azzolini, M; Biasutto, L; Chiodarelli, G; Fanin, M; La Spina, M; Mattarei, A; Paradisi, C; Romio, M; Zoratti, M, 2017
)
0.97
" However, a key problem is their short half-life and low bioavailability under in vivo conditions."( Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
Benlloch, M; Castellano, G; Dellinger, RW; Estrela, JM; Mena, S; Obrador, E; Salvador, R, 2017
)
0.46
" bioavailability promoted by the presence of HPβCD in the complex."( Pterostilbene reduces oxidative stress, prevents hypertrophy and preserves systolic function of right ventricle in cor pulmonale model.
Belló-Klein, A; Bianchi, SE; Campos-Carraro, C; Colombo, R; Dos Santos Lacerda, D; Duarte Ortiz, V; Gazzi de Lima-Seolin, B; Linck Bassani, V; Poletto Bonetto, JH; Sander da Rosa Araujo, A; Türck, P, 2017
)
1.9
" Nonetheless, the low bioavailability of resveratrol has reduced its attractiveness as a potential anti-cancer treatment."( Pterostilbene Suppresses Ovarian Cancer Growth via Induction of Apoptosis and Blockade of Cell Cycle Progression Involving Inhibition of the STAT3 Pathway.
Dellinger, TH; Finlay, J; Glackin, CA; Han, ES; Lowe, G; Roberts, CM; Wen, W, 2018
)
1.92
" Moreover, pterostilbene exhibits much greater bioavailability and bioactivity than resveratrol which warrants further investigation in the anti-cancer functions and mechanisms."( [Emerging Actions of Pterostilebene on Cancer Research].
Di, S; Gao, Y; Li, X; Ma, Z; Xu, L; Yan, X; Zhang, H; Zhang, J; Zhang, X, 2018
)
0.87
" Its high bioavailability is a major advantage for possible biomedical applications."( Pterostilbene Improves Cognitive Performance in Aged Rats: An in Vivo Study.
Azzolini, M; Berardi, N; Biasutto, L; La Spina, M; Peruzzo, R; Sale, A; Sansevero, G; Zoratti, M, 2019
)
1.96
"Pterostilbene, a phenolic compound derived from resveratrol, possesses greater bioavailability than its parent compound due to the presence of two methoxyl groups."( Effects of Pterostilbene on Diabetes, Liver Steatosis and Serum Lipids.
Aguirre, L; Fernández-Quintela, A; Gómez-Zorita, S; Milton-Laskíbar, I; Portillo, MP; Xiao, J, 2021
)
2.45
" These results suggest that pterostilbene might be a potential anticancer agent targeting both cancer cells and cancer stem-like cells of cervical cancer via the superior bioavailability to resveratrol."( Pterostilbene Suppresses both Cancer Cells and Cancer Stem-Like Cells in Cervical Cancer with Superior Bioavailability to Resveratrol.
Choi, YS; Han, JM; Jung, HJ; Shin, HJ, 2020
)
2.29
" These findings indicate that RA-based self-assembled ultrasmall nanomicelles demonstrate tremendous potential toward the improvement in the ocular bioavailability as well as a therapeutic effect of poor aqueous soluble drugs such as Pt."( Novel ultrasmall nanomicelles based on rebaudioside A: A potential nanoplatform for the ocular delivery of pterostilbene.
Song, K; Sun, M; Wu, X; Xie, W; Xin, M; Zhang, F, 2020
)
0.77
" However, most of them are rapidly metabolized and excreted, yielding very low phenolic bioavailability what makes it difficult to find out which are the mechanisms responsible for the observed bioactivity."( Neuroprotective and Anti-inflammatory Effects of Pterostilbene Metabolites in Human Neuroblastoma SH-SY5Y and RAW 264.7 Macrophage Cells.
de-Paz, MV; Lucas, R; Morales, JC; Peñalver, P; Zodio, S, 2020
)
0.81
"Pterostilbene is a revesterol analog with a long bioavailability and having potent anti-inflammatory activity in animal studies."( Pterostilbene exert an anti-arthritic effect by attenuating inflammation, oxidative stress, and alteration of gut microbiota.
Ding, H; Ding, X; Han, J; Li, X; Liu, Y; Rui, Z; Yuan, Y; Zhang, L, 2022
)
3.61
" However, the therapeutic outcomes of PS are limited by potential side effects associated with the systemic exposure and the modest bioavailability afforded by its oral administration."( Oral Delivery of Pterostilbene by L-Arginine-Mediated "Nano-Bomb" Carrier for the Treatment of Ulcerative Colitis.
Cao, Y; Li, R; Ma, Y; Wei, W; Yan, X; Yang, M; Zhang, M; Zhang, Y, 2022
)
1.06
" Indeed, due to its higher bioavailability paired with reduced toxicity compared to other stilbenes, PTS has become an attractive drug candidate for the treatment of several disease conditions, including diabetes, cancer, cardiovascular disease, neurodegenerative disorders, and aging."( New Insights into Dietary Pterostilbene: Sources, Metabolism, and Health Promotion Effects.
Ganesan, K; Mohandas, S; Nagarajan, S; Ramkumar, KM; Xu, B, 2022
)
1.02

Dosage Studied

Pterostilbene was shown to partially prevent high-fat high-fructose feeding induced liver steatosis in rats.

ExcerptRelevanceReference
" The present study was designed to compare the bioavailability, pharmacokinetics, and metabolism of resveratrol and pterostilbene following equimolar oral dosing in rats."( Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats.
Huang, Z; Kapetanovic, IM; McCormick, DL; Muzzio, M; Thompson, TN, 2011
)
0.79
" Two additional groups were dosed once intravenously with 10 and 11."( Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats.
Huang, Z; Kapetanovic, IM; McCormick, DL; Muzzio, M; Thompson, TN, 2011
)
0.58
" Among this panel, (E)-4-(2,6-difluorostyryl)-N,N-dimethylaniline (4r) inhibits Wnt signaling at nanomolar levels and inhibits the growth of human CRC cell xenografts in athymic nude mice at a dosage of 20 mg/kg."( Fluorinated N,N-dialkylaminostilbenes for Wnt pathway inhibition and colon cancer repression.
Chen, X; Evers, BM; Kril, LM; Liu, C; Rychahou, P; Shi, J; Sviripa, V; Watt, DS; Yu, T; Zhang, W, 2011
)
0.37
"Potassium oxonate-induced hyperuricemic mice were dosed by gavage with eight stilbenes."( Antihyperuricemic and nephroprotective effects of resveratrol and its analogues in hyperuricemic mice.
Hong, Y; Kong, LD; Li, Z; Liu, L; Liu, YL; Shi, YW; Wang, CP; Wang, X, 2012
)
0.38
" This study aimed to investigate the impacts of aqueous solubility, fasting, dose escalation, and dosing route on its bioavailability in Sprague-Dawley rats."( Pharmacokinetics of pterostilbene in Sprague-Dawley rats: the impacts of aqueous solubility, fasting, dose escalation, and dosing route on bioavailability.
Ho, PC; Lin, HS; Yeo, SC, 2013
)
0.71
" However, when dosed in a solution formulated with 2-hydroxypropyl-β-cyclodextrin (HP-β-CD) (15 mg/kg), PTS possessed good bioavailability (F = 59."( Pharmacokinetics of pterostilbene in Sprague-Dawley rats: the impacts of aqueous solubility, fasting, dose escalation, and dosing route on bioavailability.
Ho, PC; Lin, HS; Yeo, SC, 2013
)
0.71
" The data showed a strong dose-response relationship between Pte exposure and the characteristics of HeLa apoptosis in terms of changes in apoptotic morphology, DNA fragmentation, and activated caspases in the intrinsic apoptotic pathway."( Involvement of the Nrf2 pathway in the regulation of pterostilbene-induced apoptosis in HeLa cells via ER stress.
Chen, HY; Liu, BH; Wang, XQ; Zhang, B, 2014
)
0.65
" As regards antigenotoxicity testing, RESV and PTER showed a typical, U-shaped hormetic dose-response relationship characterized by a biphasic trend with small quantities having opposite effects to large ones."( In Vitro Safety/Protection Assessment of Resveratrol and Pterostilbene in a Human Hepatoma Cell Line (HepG2).
Blasi, F; Cossignani, L; Dominici, L; Lombardi, G; Marcotullio, MC; Moretti, M; Vannini, S; Villarini, M, 2015
)
0.66
" Dose-response analyses did not reveal a clear lipolytic effect in both species."( Pterostilbene Inhibits Lipogenic Activity similar to Resveratrol or Caffeine but Differently Modulates Lipolysis in Adipocytes.
Belles, C; Briot, A; Carpéné, C; Fernández-Quintela, A; Gomez-Zorita, S; Portillo, MP, 2017
)
1.9
" NRPT dosing was increased in each Step: Step 1250/50 mg, Step 2500/100 mg, Step 3750/150 mg and Step 41,000/200 mg."( Nicotinamide riboside with pterostilbene (NRPT) increases NAD
Dellinger, R; Guarente, LP; Parikh, SM; Rhee, EP; Simic, P; Vela Parada, XF, 2020
)
0.86
" Three subsequent dosage of PTS, ARB and PUR administered (i."( Fatty acid synthase inhibition ameliorates diabetes induced liver injury in rodent experimental model.
Bedi, O; Krishan, P; Parsad, D; Srivastava, N, 2021
)
0.62
" Pterostilbene was shown to partially prevent high-fat high-fructose feeding induced liver steatosis in rats, demonstrating a dose-response pattern."( Pterostilbene modifies triglyceride metabolism in hepatic steatosis induced by high-fat high-fructose feeding: a comparison with its analog resveratrol.
Biasutto, L; Bujanda, L; Fernández-Quintela, A; Gómez-Zorita, S; Lasa, A; Macarulla, MT; Milton-Laskibar, I; Miranda, J; Portillo, MP; Segues, N, 2021
)
2.97
" This novel preparation can enable new combinations of plant extracts and biomaterials to adiministered through NPs or other dosage forms in order to regulate and treat diseases."( Nanoparticles prepared from pterostilbene reduce blood glucose and improve diabetes complications.
Bian, L; Ma, Q; Shi, A; Wu, J; Yan, X; Zhang, P; Zhao, X, 2021
)
0.92
" We first evaluated the dose-response influence of PTE on early brain impairment after SAH."( Pterostilbene Attenuates Subarachnoid Hemorrhage-Induced Brain Injury through the SIRT1-Dependent Nrf2 Signaling Pathway.
Ding, F; Fang, J; Lu, Y; Zhang, Z; Zhao, X; Zhou, G; Zhou, J; Zhuang, Z, 2022
)
2.16
" On the other hand, drug:cyclodextrins complexes frequently provide bulk powders with low drug concentrations, which is crucial for obtention solid or semi-solid pharmaceutical dosage forms."( The challenge of improving pterostilbene (PTS) solubility for solid and semi-solid dosage forms: The obtention of binary and ternary systems.
Araújo, ASR; Bassani, VL; Benes Raabe, V; Bianchi, SE; de Carvalho Meirelles, G; de Souza Barbosa, F; Delagustin, MG; Dos Santos Lacerda, D; Martiny, S; Pittol, V; Waszczuk, M, 2023
)
1.21
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (9)

RoleDescription
antioxidantA substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
neurotransmitterAn endogenous compound that is used to transmit information across the synapse between a neuron and another cell.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
apoptosis inducerAny substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
neuroprotective agentAny compound that can be used for the treatment of neurodegenerative disorders.
anti-inflammatory agentAny compound that has anti-inflammatory effects.
radical scavengerA role played by a substance that can react readily with, and thereby eliminate, radicals.
hypoglycemic agentA drug which lowers the blood glucose level.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
stilbenolAny stilbenoid with at least one phenolic group.
methoxybenzenesAny aromatic ether that consists of a benzene skeleton substituted with one or more methoxy groups.
dietherA polyether in which the number of ether linkages is 2.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
pterostilbene biosynthesis16

Protein Targets (31)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency25.11890.177814.390939.8107AID2147
LuciferasePhotinus pyralis (common eastern firefly)Potency13.45910.007215.758889.3584AID588342
glp-1 receptor, partialHomo sapiens (human)Potency5.01190.01846.806014.1254AID624417
BRCA1Homo sapiens (human)Potency17.78280.89137.722525.1189AID624202
phosphopantetheinyl transferaseBacillus subtilisPotency56.23410.141337.9142100.0000AID1490
TDP1 proteinHomo sapiens (human)Potency22.14270.000811.382244.6684AID686978; AID686979
Microtubule-associated protein tauHomo sapiens (human)Potency11.22020.180013.557439.8107AID1460
lysosomal alpha-glucosidase preproproteinHomo sapiens (human)Potency11.22020.036619.637650.1187AID2100
NPC intracellular cholesterol transporter 1 precursorHomo sapiens (human)Potency2.51190.01262.451825.0177AID485313
mitogen-activated protein kinase 1Homo sapiens (human)Potency39.81070.039816.784239.8107AID1454
ras-related protein Rab-9AHomo sapiens (human)Potency3.16230.00022.621531.4954AID485297
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency6.44680.00798.23321,122.0200AID2546; AID2551
gemininHomo sapiens (human)Potency0.11580.004611.374133.4983AID624297
TAR DNA-binding protein 43Homo sapiens (human)Potency28.18381.778316.208135.4813AID652104
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Tyrosine-protein kinase ABL1Homo sapiens (human)IC50 (µMol)10.00000.00010.712810.0000AID264592
Cytochrome P450 1A1Homo sapiens (human)Ki0.57000.01200.94693.8000AID1452982
ATP-dependent translocase ABCB1Homo sapiens (human)IC50 (µMol)42.00000.00022.318510.0000AID264590
Neuronal acetylcholine receptor subunit alpha-4Rattus norvegicus (Norway rat)IC50 (µMol)0.82000.00030.30952.3000AID370920
Polyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)IC50 (µMol)4.58670.00011.68479.3200AID1570236; AID1570237; AID1614268
Breakpoint cluster region proteinHomo sapiens (human)IC50 (µMol)10.00000.00030.620010.0000AID264592
Neuronal acetylcholine receptor subunit beta-2Rattus norvegicus (Norway rat)IC50 (µMol)0.82000.00030.32092.3000AID370920
Ribosyldihydronicotinamide dehydrogenase [quinone]Homo sapiens (human)IC50 (µMol)5.10000.00271.62879.9000AID770333
Prostaglandin G/H synthase 1Homo sapiens (human)IC50 (µMol)0.70000.00021.557410.0000AID370919
Prostaglandin G/H synthase 2Homo sapiens (human)IC50 (µMol)0.82000.00010.995010.0000AID370920
Cytochrome P450 1B1Homo sapiens (human)Ki0.91000.00300.97417.4600AID1452983
Transient receptor potential cation channel subfamily A member 1Rattus norvegicus (Norway rat)IC50 (µMol)7.50000.45003.42437.5000AID1272522
Transient receptor potential cation channel subfamily V member 1Homo sapiens (human)IC50 (µMol)10.00000.00020.606010.0000AID1272526
NACHT, LRR and PYD domains-containing protein 3 Mus musculus (house mouse)IC50 (µMol)10.00000.00041.441910.0000AID1773851
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transient receptor potential cation channel subfamily A member 1Rattus norvegicus (Norway rat)EC50 (µMol)3.60000.06002.22238.4000AID1272523
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
FAD-linked sulfhydryl oxidase ALRHomo sapiens (human)AC500.77800.00503.212622.7870AID493248
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (374)

Processvia Protein(s)Taxonomy
response to oxidative stressTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationTyrosine-protein kinase ABL1Homo sapiens (human)
negative regulation of ubiquitin-protein transferase activityTyrosine-protein kinase ABL1Homo sapiens (human)
negative regulation of phospholipase C activityTyrosine-protein kinase ABL1Homo sapiens (human)
mitotic cell cycleTyrosine-protein kinase ABL1Homo sapiens (human)
neural tube closureTyrosine-protein kinase ABL1Homo sapiens (human)
B-1 B cell homeostasisTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of protein phosphorylationTyrosine-protein kinase ABL1Homo sapiens (human)
B cell proliferation involved in immune responseTyrosine-protein kinase ABL1Homo sapiens (human)
transitional one stage B cell differentiationTyrosine-protein kinase ABL1Homo sapiens (human)
mismatch repairTyrosine-protein kinase ABL1Homo sapiens (human)
regulation of DNA-templated transcriptionTyrosine-protein kinase ABL1Homo sapiens (human)
autophagyTyrosine-protein kinase ABL1Homo sapiens (human)
DNA damage responseTyrosine-protein kinase ABL1Homo sapiens (human)
integrin-mediated signaling pathwayTyrosine-protein kinase ABL1Homo sapiens (human)
canonical NF-kappaB signal transductionTyrosine-protein kinase ABL1Homo sapiens (human)
associative learningTyrosine-protein kinase ABL1Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damageTyrosine-protein kinase ABL1Homo sapiens (human)
response to xenobiotic stimulusTyrosine-protein kinase ABL1Homo sapiens (human)
post-embryonic developmentTyrosine-protein kinase ABL1Homo sapiens (human)
regulation of autophagyTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of endothelial cell migrationTyrosine-protein kinase ABL1Homo sapiens (human)
peptidyl-tyrosine phosphorylationTyrosine-protein kinase ABL1Homo sapiens (human)
cerebellum morphogenesisTyrosine-protein kinase ABL1Homo sapiens (human)
negative regulation of cell-cell adhesionTyrosine-protein kinase ABL1Homo sapiens (human)
microspike assemblyTyrosine-protein kinase ABL1Homo sapiens (human)
actin cytoskeleton organizationTyrosine-protein kinase ABL1Homo sapiens (human)
actin filament polymerizationTyrosine-protein kinase ABL1Homo sapiens (human)
regulation of endocytosisTyrosine-protein kinase ABL1Homo sapiens (human)
regulation of cell adhesionTyrosine-protein kinase ABL1Homo sapiens (human)
neuron differentiationTyrosine-protein kinase ABL1Homo sapiens (human)
BMP signaling pathwayTyrosine-protein kinase ABL1Homo sapiens (human)
negative regulation of BMP signaling pathwayTyrosine-protein kinase ABL1Homo sapiens (human)
regulation of axon extensionTyrosine-protein kinase ABL1Homo sapiens (human)
regulation of microtubule polymerizationTyrosine-protein kinase ABL1Homo sapiens (human)
regulation of Cdc42 protein signal transductionTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of type II interferon productionTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of interleukin-2 productionTyrosine-protein kinase ABL1Homo sapiens (human)
regulation of actin cytoskeleton organizationTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of osteoblast proliferationTyrosine-protein kinase ABL1Homo sapiens (human)
substrate adhesion-dependent cell spreadingTyrosine-protein kinase ABL1Homo sapiens (human)
cellular response to oxidative stressTyrosine-protein kinase ABL1Homo sapiens (human)
response to endoplasmic reticulum stressTyrosine-protein kinase ABL1Homo sapiens (human)
platelet-derived growth factor receptor-beta signaling pathwayTyrosine-protein kinase ABL1Homo sapiens (human)
protein modification processTyrosine-protein kinase ABL1Homo sapiens (human)
peptidyl-tyrosine autophosphorylationTyrosine-protein kinase ABL1Homo sapiens (human)
Fc-gamma receptor signaling pathway involved in phagocytosisTyrosine-protein kinase ABL1Homo sapiens (human)
neuropilin signaling pathwayTyrosine-protein kinase ABL1Homo sapiens (human)
signal transduction in response to DNA damageTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of apoptotic processTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of neuron apoptotic processTyrosine-protein kinase ABL1Homo sapiens (human)
endothelial cell migrationTyrosine-protein kinase ABL1Homo sapiens (human)
regulation of T cell differentiationTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of vasoconstrictionTyrosine-protein kinase ABL1Homo sapiens (human)
negative regulation of mitotic cell cycleTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of mitotic cell cycleTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IITyrosine-protein kinase ABL1Homo sapiens (human)
alpha-beta T cell differentiationTyrosine-protein kinase ABL1Homo sapiens (human)
protein autophosphorylationTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of fibroblast proliferationTyrosine-protein kinase ABL1Homo sapiens (human)
spleen developmentTyrosine-protein kinase ABL1Homo sapiens (human)
thymus developmentTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationTyrosine-protein kinase ABL1Homo sapiens (human)
activated T cell proliferationTyrosine-protein kinase ABL1Homo sapiens (human)
T cell receptor signaling pathwayTyrosine-protein kinase ABL1Homo sapiens (human)
B cell receptor signaling pathwayTyrosine-protein kinase ABL1Homo sapiens (human)
neuromuscular process controlling balanceTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of release of sequestered calcium ion into cytosolTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of oxidoreductase activityTyrosine-protein kinase ABL1Homo sapiens (human)
neuron apoptotic processTyrosine-protein kinase ABL1Homo sapiens (human)
negative regulation of ubiquitin-protein transferase activityTyrosine-protein kinase ABL1Homo sapiens (human)
myoblast proliferationTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of stress fiber assemblyTyrosine-protein kinase ABL1Homo sapiens (human)
establishment of localization in cellTyrosine-protein kinase ABL1Homo sapiens (human)
regulation of cell cycleTyrosine-protein kinase ABL1Homo sapiens (human)
mitochondrial depolarizationTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of focal adhesion assemblyTyrosine-protein kinase ABL1Homo sapiens (human)
Bergmann glial cell differentiationTyrosine-protein kinase ABL1Homo sapiens (human)
cardiac muscle cell proliferationTyrosine-protein kinase ABL1Homo sapiens (human)
neuroepithelial cell differentiationTyrosine-protein kinase ABL1Homo sapiens (human)
cellular response to hydrogen peroxideTyrosine-protein kinase ABL1Homo sapiens (human)
ERK1 and ERK2 cascadeTyrosine-protein kinase ABL1Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascadeTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeTyrosine-protein kinase ABL1Homo sapiens (human)
DNA conformation changeTyrosine-protein kinase ABL1Homo sapiens (human)
cellular response to lipopolysaccharideTyrosine-protein kinase ABL1Homo sapiens (human)
cellular response to transforming growth factor beta stimulusTyrosine-protein kinase ABL1Homo sapiens (human)
response to epinephrineTyrosine-protein kinase ABL1Homo sapiens (human)
negative regulation of protein serine/threonine kinase activityTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of cell migration involved in sprouting angiogenesisTyrosine-protein kinase ABL1Homo sapiens (human)
cellular senescenceTyrosine-protein kinase ABL1Homo sapiens (human)
cell-cell adhesionTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of dendrite developmentTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of substrate adhesion-dependent cell spreadingTyrosine-protein kinase ABL1Homo sapiens (human)
negative regulation of long-term synaptic potentiationTyrosine-protein kinase ABL1Homo sapiens (human)
regulation of hematopoietic stem cell differentiationTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of extracellular matrix organizationTyrosine-protein kinase ABL1Homo sapiens (human)
podocyte apoptotic processTyrosine-protein kinase ABL1Homo sapiens (human)
cellular response to dopamineTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of establishment of T cell polarityTyrosine-protein kinase ABL1Homo sapiens (human)
DN4 thymocyte differentiationTyrosine-protein kinase ABL1Homo sapiens (human)
protein localization to cytoplasmic microtubule plus-endTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of microtubule bindingTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of actin filament bindingTyrosine-protein kinase ABL1Homo sapiens (human)
regulation of modification of synaptic structureTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of blood vessel branchingTyrosine-protein kinase ABL1Homo sapiens (human)
activation of protein kinase C activityTyrosine-protein kinase ABL1Homo sapiens (human)
negative regulation of double-strand break repair via homologous recombinationTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of Wnt signaling pathway, planar cell polarity pathwayTyrosine-protein kinase ABL1Homo sapiens (human)
regulation of cell motilityTyrosine-protein kinase ABL1Homo sapiens (human)
negative regulation of endothelial cell apoptotic processTyrosine-protein kinase ABL1Homo sapiens (human)
positive regulation of T cell migrationTyrosine-protein kinase ABL1Homo sapiens (human)
negative regulation of cellular senescenceTyrosine-protein kinase ABL1Homo sapiens (human)
epidermal growth factor receptor signaling pathwayTyrosine-protein kinase ABL1Homo sapiens (human)
protein phosphorylationTyrosine-protein kinase ABL1Homo sapiens (human)
cellular response to organic cyclic compoundCytochrome P450 1A1Homo sapiens (human)
response to hypoxiaCytochrome P450 1A1Homo sapiens (human)
long-chain fatty acid metabolic processCytochrome P450 1A1Homo sapiens (human)
lipid hydroxylationCytochrome P450 1A1Homo sapiens (human)
fatty acid metabolic processCytochrome P450 1A1Homo sapiens (human)
steroid biosynthetic processCytochrome P450 1A1Homo sapiens (human)
porphyrin-containing compound metabolic processCytochrome P450 1A1Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 1A1Homo sapiens (human)
steroid metabolic processCytochrome P450 1A1Homo sapiens (human)
estrogen metabolic processCytochrome P450 1A1Homo sapiens (human)
amine metabolic processCytochrome P450 1A1Homo sapiens (human)
response to nematodeCytochrome P450 1A1Homo sapiens (human)
response to herbicideCytochrome P450 1A1Homo sapiens (human)
ethylene metabolic processCytochrome P450 1A1Homo sapiens (human)
coumarin metabolic processCytochrome P450 1A1Homo sapiens (human)
flavonoid metabolic processCytochrome P450 1A1Homo sapiens (human)
response to iron(III) ionCytochrome P450 1A1Homo sapiens (human)
insecticide metabolic processCytochrome P450 1A1Homo sapiens (human)
dibenzo-p-dioxin catabolic processCytochrome P450 1A1Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 1A1Homo sapiens (human)
response to foodCytochrome P450 1A1Homo sapiens (human)
response to lipopolysaccharideCytochrome P450 1A1Homo sapiens (human)
response to vitamin ACytochrome P450 1A1Homo sapiens (human)
response to immobilization stressCytochrome P450 1A1Homo sapiens (human)
vitamin D metabolic processCytochrome P450 1A1Homo sapiens (human)
retinol metabolic processCytochrome P450 1A1Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 1A1Homo sapiens (human)
9-cis-retinoic acid biosynthetic processCytochrome P450 1A1Homo sapiens (human)
camera-type eye developmentCytochrome P450 1A1Homo sapiens (human)
nitric oxide metabolic processCytochrome P450 1A1Homo sapiens (human)
response to arsenic-containing substanceCytochrome P450 1A1Homo sapiens (human)
digestive tract developmentCytochrome P450 1A1Homo sapiens (human)
tissue remodelingCytochrome P450 1A1Homo sapiens (human)
hydrogen peroxide biosynthetic processCytochrome P450 1A1Homo sapiens (human)
response to hyperoxiaCytochrome P450 1A1Homo sapiens (human)
maternal process involved in parturitionCytochrome P450 1A1Homo sapiens (human)
hepatocyte differentiationCytochrome P450 1A1Homo sapiens (human)
cellular response to copper ionCytochrome P450 1A1Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 1A1Homo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleCytochrome P450 1A1Homo sapiens (human)
response to 3-methylcholanthreneCytochrome P450 1A1Homo sapiens (human)
G2/M transition of mitotic cell cycleATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic metabolic processATP-dependent translocase ABCB1Homo sapiens (human)
response to xenobiotic stimulusATP-dependent translocase ABCB1Homo sapiens (human)
phospholipid translocationATP-dependent translocase ABCB1Homo sapiens (human)
terpenoid transportATP-dependent translocase ABCB1Homo sapiens (human)
regulation of response to osmotic stressATP-dependent translocase ABCB1Homo sapiens (human)
transmembrane transportATP-dependent translocase ABCB1Homo sapiens (human)
transepithelial transportATP-dependent translocase ABCB1Homo sapiens (human)
stem cell proliferationATP-dependent translocase ABCB1Homo sapiens (human)
ceramide translocationATP-dependent translocase ABCB1Homo sapiens (human)
export across plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
transport across blood-brain barrierATP-dependent translocase ABCB1Homo sapiens (human)
positive regulation of anion channel activityATP-dependent translocase ABCB1Homo sapiens (human)
carboxylic acid transmembrane transportATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic detoxification by transmembrane export across the plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic transport across blood-brain barrierATP-dependent translocase ABCB1Homo sapiens (human)
regulation of chloride transportATP-dependent translocase ABCB1Homo sapiens (human)
negative regulation of endothelial cell proliferationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukocyte chemotaxis involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukocyte migration involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene production involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene metabolic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
humoral immune responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of angiogenesisPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
lipoxygenase pathwayPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
positive regulation of bone mineralizationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
dendritic cell migrationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
glucose homeostasisPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
long-chain fatty acid biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of fat cell differentiationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of insulin secretionPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of vascular wound healingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of wound healingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of inflammatory response to woundingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of cytokine production involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of cellular response to oxidative stressPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene A4 biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of reactive oxygen species biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of response to endoplasmic reticulum stressPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of sprouting angiogenesisPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
positive regulation of leukocyte adhesion to arterial endothelial cellPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
lipoxin biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
arachidonic acid metabolic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
lipid oxidationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of cellular extravasationBreakpoint cluster region proteinHomo sapiens (human)
renal system processBreakpoint cluster region proteinHomo sapiens (human)
protein phosphorylationBreakpoint cluster region proteinHomo sapiens (human)
phagocytosisBreakpoint cluster region proteinHomo sapiens (human)
signal transductionBreakpoint cluster region proteinHomo sapiens (human)
small GTPase-mediated signal transductionBreakpoint cluster region proteinHomo sapiens (human)
brain developmentBreakpoint cluster region proteinHomo sapiens (human)
actin cytoskeleton organizationBreakpoint cluster region proteinHomo sapiens (human)
keratinocyte differentiationBreakpoint cluster region proteinHomo sapiens (human)
regulation of Rho protein signal transductionBreakpoint cluster region proteinHomo sapiens (human)
inner ear morphogenesisBreakpoint cluster region proteinHomo sapiens (human)
regulation of vascular permeabilityBreakpoint cluster region proteinHomo sapiens (human)
neutrophil degranulationBreakpoint cluster region proteinHomo sapiens (human)
negative regulation of neutrophil degranulationBreakpoint cluster region proteinHomo sapiens (human)
focal adhesion assemblyBreakpoint cluster region proteinHomo sapiens (human)
homeostasis of number of cellsBreakpoint cluster region proteinHomo sapiens (human)
negative regulation of inflammatory responseBreakpoint cluster region proteinHomo sapiens (human)
positive regulation of phagocytosisBreakpoint cluster region proteinHomo sapiens (human)
modulation of chemical synaptic transmissionBreakpoint cluster region proteinHomo sapiens (human)
neuromuscular process controlling balanceBreakpoint cluster region proteinHomo sapiens (human)
regulation of small GTPase mediated signal transductionBreakpoint cluster region proteinHomo sapiens (human)
regulation of cell cycleBreakpoint cluster region proteinHomo sapiens (human)
definitive hemopoiesisBreakpoint cluster region proteinHomo sapiens (human)
negative regulation of respiratory burstBreakpoint cluster region proteinHomo sapiens (human)
negative regulation of blood vessel remodelingBreakpoint cluster region proteinHomo sapiens (human)
intracellular protein transmembrane transportBreakpoint cluster region proteinHomo sapiens (human)
cellular response to lipopolysaccharideBreakpoint cluster region proteinHomo sapiens (human)
activation of GTPase activityBreakpoint cluster region proteinHomo sapiens (human)
macrophage migrationBreakpoint cluster region proteinHomo sapiens (human)
negative regulation of macrophage migrationBreakpoint cluster region proteinHomo sapiens (human)
negative regulation of reactive oxygen species metabolic processBreakpoint cluster region proteinHomo sapiens (human)
quinone catabolic processRibosyldihydronicotinamide dehydrogenase [quinone]Homo sapiens (human)
prostaglandin biosynthetic processProstaglandin G/H synthase 1Homo sapiens (human)
response to oxidative stressProstaglandin G/H synthase 1Homo sapiens (human)
regulation of blood pressureProstaglandin G/H synthase 1Homo sapiens (human)
cyclooxygenase pathwayProstaglandin G/H synthase 1Homo sapiens (human)
regulation of cell population proliferationProstaglandin G/H synthase 1Homo sapiens (human)
cellular oxidant detoxificationProstaglandin G/H synthase 1Homo sapiens (human)
prostaglandin biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
angiogenesisProstaglandin G/H synthase 2Homo sapiens (human)
response to oxidative stressProstaglandin G/H synthase 2Homo sapiens (human)
embryo implantationProstaglandin G/H synthase 2Homo sapiens (human)
learningProstaglandin G/H synthase 2Homo sapiens (human)
memoryProstaglandin G/H synthase 2Homo sapiens (human)
regulation of blood pressureProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of cell population proliferationProstaglandin G/H synthase 2Homo sapiens (human)
response to xenobiotic stimulusProstaglandin G/H synthase 2Homo sapiens (human)
response to nematodeProstaglandin G/H synthase 2Homo sapiens (human)
response to fructoseProstaglandin G/H synthase 2Homo sapiens (human)
response to manganese ionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vascular endothelial growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
cyclooxygenase pathwayProstaglandin G/H synthase 2Homo sapiens (human)
bone mineralizationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of prostaglandin biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of fever generationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of synaptic plasticityProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of synaptic transmission, dopaminergicProstaglandin G/H synthase 2Homo sapiens (human)
prostaglandin secretionProstaglandin G/H synthase 2Homo sapiens (human)
response to estradiolProstaglandin G/H synthase 2Homo sapiens (human)
response to lipopolysaccharideProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylationProstaglandin G/H synthase 2Homo sapiens (human)
response to vitamin DProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to heatProstaglandin G/H synthase 2Homo sapiens (human)
response to tumor necrosis factorProstaglandin G/H synthase 2Homo sapiens (human)
maintenance of blood-brain barrierProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of protein import into nucleusProstaglandin G/H synthase 2Homo sapiens (human)
hair cycleProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of apoptotic processProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of nitric oxide biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of cell cycleProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vasoconstrictionProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of smooth muscle contractionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of smooth muscle contractionProstaglandin G/H synthase 2Homo sapiens (human)
decidualizationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of smooth muscle cell proliferationProstaglandin G/H synthase 2Homo sapiens (human)
regulation of inflammatory responseProstaglandin G/H synthase 2Homo sapiens (human)
brown fat cell differentiationProstaglandin G/H synthase 2Homo sapiens (human)
response to glucocorticoidProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of calcium ion transportProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of synaptic transmission, glutamatergicProstaglandin G/H synthase 2Homo sapiens (human)
response to fatty acidProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to mechanical stimulusProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to lead ionProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to ATPProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to hypoxiaProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to non-ionic osmotic stressProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to fluid shear stressProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of transforming growth factor beta productionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of cell migration involved in sprouting angiogenesisProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of fibroblast growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of brown fat cell differentiationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of platelet-derived growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
cellular oxidant detoxificationProstaglandin G/H synthase 2Homo sapiens (human)
regulation of neuroinflammatory responseProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stressProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to homocysteineProstaglandin G/H synthase 2Homo sapiens (human)
response to angiotensinProstaglandin G/H synthase 2Homo sapiens (human)
neutrophil homeostasiscAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
cAMP catabolic processcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
neutrophil chemotaxiscAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
positive regulation of type II interferon productioncAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
positive regulation of interleukin-2 productioncAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
T cell receptor signaling pathwaycAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
leukocyte migrationcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
cellular response to lipopolysaccharidecAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
cellular response to xenobiotic stimuluscAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
cellular response to epinephrine stimuluscAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathwaycAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
regulation of cardiac muscle cell contractioncAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
negative regulation of relaxation of cardiac musclecAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
regulation of calcium ion transmembrane transport via high voltage-gated calcium channelcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
cAMP-mediated signalingcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
negative regulation of protein phosphorylationTAR DNA-binding protein 43Homo sapiens (human)
mRNA processingTAR DNA-binding protein 43Homo sapiens (human)
RNA splicingTAR DNA-binding protein 43Homo sapiens (human)
negative regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
regulation of protein stabilityTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of insulin secretionTAR DNA-binding protein 43Homo sapiens (human)
response to endoplasmic reticulum stressTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of protein import into nucleusTAR DNA-binding protein 43Homo sapiens (human)
regulation of circadian rhythmTAR DNA-binding protein 43Homo sapiens (human)
regulation of apoptotic processTAR DNA-binding protein 43Homo sapiens (human)
negative regulation by host of viral transcriptionTAR DNA-binding protein 43Homo sapiens (human)
rhythmic processTAR DNA-binding protein 43Homo sapiens (human)
regulation of cell cycleTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA destabilizationTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA stabilizationTAR DNA-binding protein 43Homo sapiens (human)
nuclear inner membrane organizationTAR DNA-binding protein 43Homo sapiens (human)
amyloid fibril formationTAR DNA-binding protein 43Homo sapiens (human)
regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
cellular response to organic cyclic compoundCytochrome P450 1B1Homo sapiens (human)
angiogenesisCytochrome P450 1B1Homo sapiens (human)
trabecular meshwork developmentCytochrome P450 1B1Homo sapiens (human)
DNA modificationCytochrome P450 1B1Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 1B1Homo sapiens (human)
nitric oxide biosynthetic processCytochrome P450 1B1Homo sapiens (human)
cell adhesionCytochrome P450 1B1Homo sapiens (human)
response to nutrientCytochrome P450 1B1Homo sapiens (human)
steroid metabolic processCytochrome P450 1B1Homo sapiens (human)
estrogen metabolic processCytochrome P450 1B1Homo sapiens (human)
negative regulation of cell population proliferationCytochrome P450 1B1Homo sapiens (human)
male gonad developmentCytochrome P450 1B1Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to oxidative stressCytochrome P450 1B1Homo sapiens (human)
toxin metabolic processCytochrome P450 1B1Homo sapiens (human)
positive regulation of vascular endothelial growth factor productionCytochrome P450 1B1Homo sapiens (human)
positive regulation of smooth muscle cell migrationCytochrome P450 1B1Homo sapiens (human)
sterol metabolic processCytochrome P450 1B1Homo sapiens (human)
arachidonic acid metabolic processCytochrome P450 1B1Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 1B1Homo sapiens (human)
collagen fibril organizationCytochrome P450 1B1Homo sapiens (human)
adrenal gland developmentCytochrome P450 1B1Homo sapiens (human)
negative regulation of cell migrationCytochrome P450 1B1Homo sapiens (human)
negative regulation of NF-kappaB transcription factor activityCytochrome P450 1B1Homo sapiens (human)
response to follicle-stimulating hormoneCytochrome P450 1B1Homo sapiens (human)
response to estradiolCytochrome P450 1B1Homo sapiens (human)
negative regulation of cell adhesion mediated by integrinCytochrome P450 1B1Homo sapiens (human)
benzene-containing compound metabolic processCytochrome P450 1B1Homo sapiens (human)
retinol metabolic processCytochrome P450 1B1Homo sapiens (human)
retinal metabolic processCytochrome P450 1B1Homo sapiens (human)
positive regulation of apoptotic processCytochrome P450 1B1Homo sapiens (human)
blood vessel endothelial cell migrationCytochrome P450 1B1Homo sapiens (human)
endothelial cell migrationCytochrome P450 1B1Homo sapiens (human)
estrous cycleCytochrome P450 1B1Homo sapiens (human)
positive regulation of translationCytochrome P450 1B1Homo sapiens (human)
positive regulation of angiogenesisCytochrome P450 1B1Homo sapiens (human)
positive regulation of receptor signaling pathway via JAK-STATCytochrome P450 1B1Homo sapiens (human)
membrane lipid catabolic processCytochrome P450 1B1Homo sapiens (human)
response to arsenic-containing substanceCytochrome P450 1B1Homo sapiens (human)
blood vessel morphogenesisCytochrome P450 1B1Homo sapiens (human)
retinal blood vessel morphogenesisCytochrome P450 1B1Homo sapiens (human)
ganglion developmentCytochrome P450 1B1Homo sapiens (human)
cellular response to hydrogen peroxideCytochrome P450 1B1Homo sapiens (human)
cellular response to cAMPCytochrome P450 1B1Homo sapiens (human)
cellular response to tumor necrosis factorCytochrome P450 1B1Homo sapiens (human)
cellular response to luteinizing hormone stimulusCytochrome P450 1B1Homo sapiens (human)
cellular response to cortisol stimulusCytochrome P450 1B1Homo sapiens (human)
cellular response to progesterone stimulusCytochrome P450 1B1Homo sapiens (human)
response to dexamethasoneCytochrome P450 1B1Homo sapiens (human)
endothelial cell-cell adhesionCytochrome P450 1B1Homo sapiens (human)
response to indole-3-methanolCytochrome P450 1B1Homo sapiens (human)
cellular response to toxic substanceCytochrome P450 1B1Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 1B1Homo sapiens (human)
response to 3-methylcholanthreneCytochrome P450 1B1Homo sapiens (human)
regulation of reactive oxygen species metabolic processCytochrome P450 1B1Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCytochrome P450 1B1Homo sapiens (human)
positive regulation of DNA biosynthetic processCytochrome P450 1B1Homo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IITransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
fever generationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
microglial cell activationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
diet induced thermogenesisTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
peptide secretionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of systemic arterial blood pressureTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
lipid metabolic processTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cell surface receptor signaling pathwayTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
chemosensory behaviorTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of heart rateTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of mitochondrial membrane potentialTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
glutamate secretionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to heatTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
positive regulation of apoptotic processTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
response to peptide hormoneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
positive regulation of nitric oxide biosynthetic processTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
behavioral response to painTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
sensory perception of mechanical stimulusTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
detection of temperature stimulus involved in thermoceptionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
detection of temperature stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
protein homotetramerizationTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
excitatory postsynaptic potentialTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
smooth muscle contraction involved in micturitionTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to alkaloidTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to ATPTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to tumor necrosis factorTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to acidic pHTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to temperature stimulusTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
negative regulation of establishment of blood-brain barrierTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium ion import across plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
response to capsazepineTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cellular response to nerve growth factor stimulusTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (107)

Processvia Protein(s)Taxonomy
supercoiled DNA bindingTyrosine-protein kinase ABL1Homo sapiens (human)
magnesium ion bindingTyrosine-protein kinase ABL1Homo sapiens (human)
four-way junction DNA bindingTyrosine-protein kinase ABL1Homo sapiens (human)
bubble DNA bindingTyrosine-protein kinase ABL1Homo sapiens (human)
phosphotyrosine residue bindingTyrosine-protein kinase ABL1Homo sapiens (human)
DNA bindingTyrosine-protein kinase ABL1Homo sapiens (human)
transcription coactivator activityTyrosine-protein kinase ABL1Homo sapiens (human)
actin monomer bindingTyrosine-protein kinase ABL1Homo sapiens (human)
nicotinate-nucleotide adenylyltransferase activityTyrosine-protein kinase ABL1Homo sapiens (human)
protein kinase activityTyrosine-protein kinase ABL1Homo sapiens (human)
protein tyrosine kinase activityTyrosine-protein kinase ABL1Homo sapiens (human)
non-membrane spanning protein tyrosine kinase activityTyrosine-protein kinase ABL1Homo sapiens (human)
protein kinase C bindingTyrosine-protein kinase ABL1Homo sapiens (human)
protein bindingTyrosine-protein kinase ABL1Homo sapiens (human)
ATP bindingTyrosine-protein kinase ABL1Homo sapiens (human)
kinase activityTyrosine-protein kinase ABL1Homo sapiens (human)
SH3 domain bindingTyrosine-protein kinase ABL1Homo sapiens (human)
syntaxin bindingTyrosine-protein kinase ABL1Homo sapiens (human)
manganese ion bindingTyrosine-protein kinase ABL1Homo sapiens (human)
neuropilin bindingTyrosine-protein kinase ABL1Homo sapiens (human)
SH2 domain bindingTyrosine-protein kinase ABL1Homo sapiens (human)
ephrin receptor bindingTyrosine-protein kinase ABL1Homo sapiens (human)
actin filament bindingTyrosine-protein kinase ABL1Homo sapiens (human)
mitogen-activated protein kinase bindingTyrosine-protein kinase ABL1Homo sapiens (human)
proline-rich region bindingTyrosine-protein kinase ABL1Homo sapiens (human)
delta-catenin bindingTyrosine-protein kinase ABL1Homo sapiens (human)
sequence-specific double-stranded DNA bindingTyrosine-protein kinase ABL1Homo sapiens (human)
monooxygenase activityCytochrome P450 1A1Homo sapiens (human)
iron ion bindingCytochrome P450 1A1Homo sapiens (human)
protein bindingCytochrome P450 1A1Homo sapiens (human)
arachidonic acid monooxygenase activityCytochrome P450 1A1Homo sapiens (human)
oxidoreductase activityCytochrome P450 1A1Homo sapiens (human)
oxidoreductase activity, acting on diphenols and related substances as donorsCytochrome P450 1A1Homo sapiens (human)
flavonoid 3'-monooxygenase activityCytochrome P450 1A1Homo sapiens (human)
oxygen bindingCytochrome P450 1A1Homo sapiens (human)
enzyme bindingCytochrome P450 1A1Homo sapiens (human)
heme bindingCytochrome P450 1A1Homo sapiens (human)
Hsp70 protein bindingCytochrome P450 1A1Homo sapiens (human)
demethylase activityCytochrome P450 1A1Homo sapiens (human)
Hsp90 protein bindingCytochrome P450 1A1Homo sapiens (human)
aromatase activityCytochrome P450 1A1Homo sapiens (human)
vitamin D 24-hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
long-chain fatty acid omega-hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 1A1Homo sapiens (human)
long-chain fatty acid omega-1 hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
protein bindingATP-dependent translocase ABCB1Homo sapiens (human)
ATP bindingATP-dependent translocase ABCB1Homo sapiens (human)
ABC-type xenobiotic transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
efflux transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
ATP hydrolysis activityATP-dependent translocase ABCB1Homo sapiens (human)
transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
ubiquitin protein ligase bindingATP-dependent translocase ABCB1Homo sapiens (human)
ATPase-coupled transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
carboxylic acid transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
phosphatidylcholine floppase activityATP-dependent translocase ABCB1Homo sapiens (human)
phosphatidylethanolamine flippase activityATP-dependent translocase ABCB1Homo sapiens (human)
ceramide floppase activityATP-dependent translocase ABCB1Homo sapiens (human)
floppase activityATP-dependent translocase ABCB1Homo sapiens (human)
arachidonate 5-lipoxygenase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
arachidonate 12(S)-lipoxygenase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
iron ion bindingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
protein bindingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
hydrolase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
arachidonate 8(S)-lipoxygenase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
protein serine/threonine kinase activityBreakpoint cluster region proteinHomo sapiens (human)
protein tyrosine kinase activityBreakpoint cluster region proteinHomo sapiens (human)
guanyl-nucleotide exchange factor activityBreakpoint cluster region proteinHomo sapiens (human)
GTPase activator activityBreakpoint cluster region proteinHomo sapiens (human)
protein bindingBreakpoint cluster region proteinHomo sapiens (human)
ATP bindingBreakpoint cluster region proteinHomo sapiens (human)
protein serine kinase activityBreakpoint cluster region proteinHomo sapiens (human)
dihydronicotinamide riboside quinone reductase activityRibosyldihydronicotinamide dehydrogenase [quinone]Homo sapiens (human)
protein bindingRibosyldihydronicotinamide dehydrogenase [quinone]Homo sapiens (human)
zinc ion bindingRibosyldihydronicotinamide dehydrogenase [quinone]Homo sapiens (human)
electron transfer activityRibosyldihydronicotinamide dehydrogenase [quinone]Homo sapiens (human)
oxidoreductase activityRibosyldihydronicotinamide dehydrogenase [quinone]Homo sapiens (human)
oxidoreductase activity, acting on other nitrogenous compounds as donorsRibosyldihydronicotinamide dehydrogenase [quinone]Homo sapiens (human)
chloride ion bindingRibosyldihydronicotinamide dehydrogenase [quinone]Homo sapiens (human)
protein homodimerization activityRibosyldihydronicotinamide dehydrogenase [quinone]Homo sapiens (human)
FAD bindingRibosyldihydronicotinamide dehydrogenase [quinone]Homo sapiens (human)
melatonin bindingRibosyldihydronicotinamide dehydrogenase [quinone]Homo sapiens (human)
resveratrol bindingRibosyldihydronicotinamide dehydrogenase [quinone]Homo sapiens (human)
NAD(P)H dehydrogenase (quinone) activityRibosyldihydronicotinamide dehydrogenase [quinone]Homo sapiens (human)
peroxidase activityProstaglandin G/H synthase 1Homo sapiens (human)
prostaglandin-endoperoxide synthase activityProstaglandin G/H synthase 1Homo sapiens (human)
protein bindingProstaglandin G/H synthase 1Homo sapiens (human)
heme bindingProstaglandin G/H synthase 1Homo sapiens (human)
metal ion bindingProstaglandin G/H synthase 1Homo sapiens (human)
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygenProstaglandin G/H synthase 1Homo sapiens (human)
peroxidase activityProstaglandin G/H synthase 2Homo sapiens (human)
prostaglandin-endoperoxide synthase activityProstaglandin G/H synthase 2Homo sapiens (human)
protein bindingProstaglandin G/H synthase 2Homo sapiens (human)
enzyme bindingProstaglandin G/H synthase 2Homo sapiens (human)
heme bindingProstaglandin G/H synthase 2Homo sapiens (human)
protein homodimerization activityProstaglandin G/H synthase 2Homo sapiens (human)
metal ion bindingProstaglandin G/H synthase 2Homo sapiens (human)
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygenProstaglandin G/H synthase 2Homo sapiens (human)
3',5'-cyclic-AMP phosphodiesterase activitycAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
calcium channel regulator activitycAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
protein bindingcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
cAMP bindingcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
gamma-tubulin bindingcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
transmembrane transporter bindingcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
metal ion bindingcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
3',5'-cyclic-GMP phosphodiesterase activitycAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
double-stranded DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
RNA bindingTAR DNA-binding protein 43Homo sapiens (human)
mRNA 3'-UTR bindingTAR DNA-binding protein 43Homo sapiens (human)
protein bindingTAR DNA-binding protein 43Homo sapiens (human)
lipid bindingTAR DNA-binding protein 43Homo sapiens (human)
identical protein bindingTAR DNA-binding protein 43Homo sapiens (human)
pre-mRNA intronic bindingTAR DNA-binding protein 43Homo sapiens (human)
molecular condensate scaffold activityTAR DNA-binding protein 43Homo sapiens (human)
monooxygenase activityCytochrome P450 1B1Homo sapiens (human)
iron ion bindingCytochrome P450 1B1Homo sapiens (human)
protein bindingCytochrome P450 1B1Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 1B1Homo sapiens (human)
heme bindingCytochrome P450 1B1Homo sapiens (human)
aromatase activityCytochrome P450 1B1Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 1B1Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 1B1Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygenCytochrome P450 1B1Homo sapiens (human)
transmembrane signaling receptor activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
extracellular ligand-gated monoatomic ion channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
excitatory extracellular ligand-gated monoatomic ion channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
voltage-gated calcium channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calcium channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
protein bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
calmodulin bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
ATP bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
intracellularly gated calcium channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
chloride channel regulator activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
phosphatidylinositol bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
metal ion bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
phosphoprotein bindingTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
temperature-gated ion channel activityTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (60)

Processvia Protein(s)Taxonomy
ruffleTyrosine-protein kinase ABL1Homo sapiens (human)
nucleusTyrosine-protein kinase ABL1Homo sapiens (human)
nucleoplasmTyrosine-protein kinase ABL1Homo sapiens (human)
nucleolusTyrosine-protein kinase ABL1Homo sapiens (human)
cytoplasmTyrosine-protein kinase ABL1Homo sapiens (human)
mitochondrionTyrosine-protein kinase ABL1Homo sapiens (human)
cytosolTyrosine-protein kinase ABL1Homo sapiens (human)
actin cytoskeletonTyrosine-protein kinase ABL1Homo sapiens (human)
nuclear bodyTyrosine-protein kinase ABL1Homo sapiens (human)
dendriteTyrosine-protein kinase ABL1Homo sapiens (human)
growth coneTyrosine-protein kinase ABL1Homo sapiens (human)
nuclear membraneTyrosine-protein kinase ABL1Homo sapiens (human)
neuronal cell bodyTyrosine-protein kinase ABL1Homo sapiens (human)
perinuclear region of cytoplasmTyrosine-protein kinase ABL1Homo sapiens (human)
postsynapseTyrosine-protein kinase ABL1Homo sapiens (human)
protein-containing complexTyrosine-protein kinase ABL1Homo sapiens (human)
plasma membraneTyrosine-protein kinase ABL1Homo sapiens (human)
mitochondrial inner membraneCytochrome P450 1A1Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 1A1Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A1Homo sapiens (human)
cytoplasmATP-dependent translocase ABCB1Homo sapiens (human)
plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
cell surfaceATP-dependent translocase ABCB1Homo sapiens (human)
membraneATP-dependent translocase ABCB1Homo sapiens (human)
apical plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
extracellular exosomeATP-dependent translocase ABCB1Homo sapiens (human)
external side of apical plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
extracellular regionPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
extracellular spacePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear envelopePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear envelope lumenPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nucleoplasmPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
cytosolPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear matrixPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear membranePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
secretory granule lumenPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
perinuclear region of cytoplasmPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
ficolin-1-rich granule lumenPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear envelopePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
cytosolBreakpoint cluster region proteinHomo sapiens (human)
plasma membraneBreakpoint cluster region proteinHomo sapiens (human)
postsynaptic densityBreakpoint cluster region proteinHomo sapiens (human)
membraneBreakpoint cluster region proteinHomo sapiens (human)
axonBreakpoint cluster region proteinHomo sapiens (human)
dendritic spineBreakpoint cluster region proteinHomo sapiens (human)
extracellular exosomeBreakpoint cluster region proteinHomo sapiens (human)
protein-containing complexBreakpoint cluster region proteinHomo sapiens (human)
Schaffer collateral - CA1 synapseBreakpoint cluster region proteinHomo sapiens (human)
glutamatergic synapseBreakpoint cluster region proteinHomo sapiens (human)
membraneBreakpoint cluster region proteinHomo sapiens (human)
nucleoplasmRibosyldihydronicotinamide dehydrogenase [quinone]Homo sapiens (human)
cytosolRibosyldihydronicotinamide dehydrogenase [quinone]Homo sapiens (human)
extracellular exosomeRibosyldihydronicotinamide dehydrogenase [quinone]Homo sapiens (human)
cytosolRibosyldihydronicotinamide dehydrogenase [quinone]Homo sapiens (human)
photoreceptor outer segmentProstaglandin G/H synthase 1Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 1Homo sapiens (human)
endoplasmic reticulum membraneProstaglandin G/H synthase 1Homo sapiens (human)
Golgi apparatusProstaglandin G/H synthase 1Homo sapiens (human)
intracellular membrane-bounded organelleProstaglandin G/H synthase 1Homo sapiens (human)
extracellular exosomeProstaglandin G/H synthase 1Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 1Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 1Homo sapiens (human)
nuclear inner membraneProstaglandin G/H synthase 2Homo sapiens (human)
nuclear outer membraneProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulumProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum lumenProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum membraneProstaglandin G/H synthase 2Homo sapiens (human)
caveolaProstaglandin G/H synthase 2Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 2Homo sapiens (human)
protein-containing complexProstaglandin G/H synthase 2Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 2Homo sapiens (human)
centrosomecAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
cytosolcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
synaptic vesiclecAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
postsynaptic densitycAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
Z disccAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
dendritic spinecAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
excitatory synapsecAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
gamma-tubulin complexcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
voltage-gated calcium channel complexcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
nucleuscAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
perinuclear region of cytoplasmcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
cytosolcAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)
intracellular non-membrane-bounded organelleTAR DNA-binding protein 43Homo sapiens (human)
nucleusTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
perichromatin fibrilsTAR DNA-binding protein 43Homo sapiens (human)
mitochondrionTAR DNA-binding protein 43Homo sapiens (human)
cytoplasmic stress granuleTAR DNA-binding protein 43Homo sapiens (human)
nuclear speckTAR DNA-binding protein 43Homo sapiens (human)
interchromatin granuleTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
chromatinTAR DNA-binding protein 43Homo sapiens (human)
mitochondrionCytochrome P450 1B1Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 1B1Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1B1Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
external side of plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
dendritic spine membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
neuronal cell bodyTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
postsynaptic membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
plasma membraneTransient receptor potential cation channel subfamily V member 1Homo sapiens (human)
cytosolNACHT, LRR and PYD domains-containing protein 3 Mus musculus (house mouse)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (228)

Assay IDTitleYearJournalArticle
AID1069488Inhibition of Rac1 in human MDA-MB-231 cells at 2 uM after 30 mins by G-LISA activity assay2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Urokinase-type plasminogen activator expression and Rac1/WAVE-2/Arp2/3 pathway are blocked by pterostilbene to suppress cell migration and invasion in MDA-MB-231 cells.
AID1183065Antifungal activity against Candida guilliermondii ATCC 6260 assessed as growth inhibition after 48 hrs by broth microdilution method2014Journal of natural products, Jul-25, Volume: 77, Issue:7
Antifungal activity of resveratrol derivatives against Candida species.
AID1083164Antifungal activity against Eutypa lata BX1-10 assessed as growth inhibition measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID1069489Inhibition of DNA binding of NF-kappaB (unknown origin) on uPA promoter at 10 uM by ChIP assay2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Urokinase-type plasminogen activator expression and Rac1/WAVE-2/Arp2/3 pathway are blocked by pterostilbene to suppress cell migration and invasion in MDA-MB-231 cells.
AID510869Cytotoxicity against human Caco-2 cells after 3 days by [3H]thymidine incorporation assay2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
In vitro and in vivo studies on stilbene analogs as potential treatment agents for colon cancer.
AID1083154Antifungal activity against Diplodia seriata BoF98-1 assessed as growth inhibition measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID1371456Cmax in mouse at 100 mg/kg, po by HPLC method2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1272525Agonist activity at human TRPV1 expressed in HEK293 cells assessed as induction of intracellular calcium level relative to allyl isothiocyanate2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
TRPA1 channels as targets for resveratrol and related stilbenoids.
AID403243Antihyperglycemic activity in streptozotocin-induced nonfasted diabetic rat assessed as decrease in blood glucose level at 20 mg/kg, po administered for 3 days measured 1 hr after last dose1997Journal of natural products, Jun, Volume: 60, Issue:6
Antihyperglycemic activity of phenolics from Pterocarpus marsupium.
AID264591Proapoptotic activity against MDR human HL60R cell line2006Journal of medicinal chemistry, May-18, Volume: 49, Issue:10
Identification of a terphenyl derivative that blocks the cell cycle in the G0-G1 phase and induces differentiation in leukemia cells.
AID1354541Antiinflammatory activity in mouse J774 cells assessed as reduction in LPS-induced IL6 expression after 24 hrs by ELISA2018Journal of natural products, 05-25, Volume: 81, Issue:5
Natural Stilbenoids Have Anti-Inflammatory Properties in Vivo and Down-Regulate the Production of Inflammatory Mediators NO, IL6, and MCP1 Possibly in a PI3K/Akt-Dependent Manner.
AID1183064Antifungal activity against Candida glabrata ATCC 90030 assessed as growth inhibition after 48 hrs by broth microdilution method2014Journal of natural products, Jul-25, Volume: 77, Issue:7
Antifungal activity of resveratrol derivatives against Candida species.
AID1183068Antifungal activity against Candida krusei ATCC 6258 assessed as growth inhibition after 48 hrs by broth microdilution method2014Journal of natural products, Jul-25, Volume: 77, Issue:7
Antifungal activity of resveratrol derivatives against Candida species.
AID1183062Antifungal activity against Candida dubliniensis ATCC MYA-646 assessed as growth inhibition after 48 hrs by broth microdilution method2014Journal of natural products, Jul-25, Volume: 77, Issue:7
Antifungal activity of resveratrol derivatives against Candida species.
AID1083160Antifungal activity against Neofusicoccum luteum CBS110299 assessed as growth inhibition measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID264589Proapoptotic activity against human HL60 cell line2006Journal of medicinal chemistry, May-18, Volume: 49, Issue:10
Identification of a terphenyl derivative that blocks the cell cycle in the G0-G1 phase and induces differentiation in leukemia cells.
AID1309126Activation of Nrf2 in mouse MIN6 cells assessed as upregulation of GST1-ARE-luciferase incubated for 8 hrs by luminometric assay relative to control2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Pterostilbene-mediated Nrf2 activation: Mechanistic insights on Keap1:Nrf2 interface.
AID1083155Antifungal activity against Diplodia seriata BoF99-1 assessed as growth inhibition measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID370921Inhibition of TNFalpha induced NF-kappaB activation in human 293 cells after 24 hrs by luciferase reporter gene assay2009Bioorganic & medicinal chemistry, Feb-01, Volume: 17, Issue:3
Synthesis and biological evaluation of a library of resveratrol analogues as inhibitors of COX-1, COX-2 and NF-kappaB.
AID57707In vitro growth inhibition of DU-145 (human prostate carcinoma) cell line.2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin phosphate.
AID1081912Antifungal activity against Botryotinia fuckeliana assessed as growth inhibition after 48 hr by NCCLS M27-A broth microdilution method2011Journal of agricultural and food chemistry, Mar-09, Volume: 59, Issue:5
Biological activity of peanut (Arachis hypogaea) phytoalexins and selected natural and synthetic Stilbenoids.
AID1773848Inhibition of NLRP3 inflammasome activation in LPS-stimulated mouse J774A.1 cells assessed as inhibition of cell pyrolysis at 20 uM incubated for 1 hr followed by ATP addition and measured after 30 mins by Hoechst 33342/propidium iodide staining based hig2021Journal of medicinal chemistry, 09-23, Volume: 64, Issue:18
Discovery of Novel Pterostilbene-Based Derivatives as Potent and Orally Active NLRP3 Inflammasome Inhibitors with Inflammatory Activity for Colitis.
AID470666Cytotoxicity against mouse B16-BL6 cells after 72 hrs by MTT assay2009Journal of natural products, Sep, Volume: 72, Issue:9
Cytotoxic constituents of Soymida febrifuga from Myanmar.
AID1352500Toxicity in 3 hrs post fertilized zebra fish AB embryo after 93 hrs2018European journal of medicinal chemistry, Feb-25, Volume: 146Alkylated resveratrol prodrugs and metabolites as potential therapeutics for neurodegenerative diseases.
AID1371395Cytotoxicity against human COLO201 cells assessed as cell viability at 34 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1069496Antiinvasion activity in human MDA-MB-231 cells reduction of cell assessed as inhibition of FBS-induced cell invaded to lower surface at 5 uM after 24 hrs2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Urokinase-type plasminogen activator expression and Rac1/WAVE-2/Arp2/3 pathway are blocked by pterostilbene to suppress cell migration and invasion in MDA-MB-231 cells.
AID1354540Antiinflammatory activity in mouse J774 cells assessed as reduction in LPS-induced nitric oxide production after 24 hrs by Griess assay2018Journal of natural products, 05-25, Volume: 81, Issue:5
Natural Stilbenoids Have Anti-Inflammatory Properties in Vivo and Down-Regulate the Production of Inflammatory Mediators NO, IL6, and MCP1 Possibly in a PI3K/Akt-Dependent Manner.
AID1183063Antifungal activity against Candida famata VKMY-9 assessed as growth inhibition after 48 hrs by broth microdilution method2014Journal of natural products, Jul-25, Volume: 77, Issue:7
Antifungal activity of resveratrol derivatives against Candida species.
AID1317152Oral bioavailability in rat at 56 or 168 mg/kg/day administered through gavage for 14 consecutive days by HPLC analysis2016European journal of medicinal chemistry, Aug-25, Volume: 119How much successful are the medicinal chemists in modulation of SIRT1: A critical review.
AID1371375Cytotoxicity against human PANC1 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1069486Inhibition of Rac1 in human MDA-MB-231 cells at 10 uM after 30 mins by G-LISA activity assay2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Urokinase-type plasminogen activator expression and Rac1/WAVE-2/Arp2/3 pathway are blocked by pterostilbene to suppress cell migration and invasion in MDA-MB-231 cells.
AID1083162Antifungal activity against Neofusicoccum parvum Bp0014 assessed as growth inhibition measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID1354549Antiinflammatory activity in carrageenan induced C57BL/6 mouse model of inflammation assessed as reduction in IL6 expression in hind paw at 30 mg/kg, ip pretreated for 1 to 2 hrs followed by carrageenan challenge measured after 6 hrs by ELISA2018Journal of natural products, 05-25, Volume: 81, Issue:5
Natural Stilbenoids Have Anti-Inflammatory Properties in Vivo and Down-Regulate the Production of Inflammatory Mediators NO, IL6, and MCP1 Possibly in a PI3K/Akt-Dependent Manner.
AID1309123Activation of Nrf2 in mouse MIN6 cells assessed as increase in nuclear Nrf2 translocation by Western blot analysis2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Pterostilbene-mediated Nrf2 activation: Mechanistic insights on Keap1:Nrf2 interface.
AID1272523Agonist activity at rat TRPA1 expressed in HEK293 cells assessed as induction of intracellular calcium level2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
TRPA1 channels as targets for resveratrol and related stilbenoids.
AID1183061Antifungal activity against Candida albicans SC5314 ATCC MYA-2876 assessed as growth inhibition after 48 hrs by broth microdilution method2014Journal of natural products, Jul-25, Volume: 77, Issue:7
Antifungal activity of resveratrol derivatives against Candida species.
AID1290889Antioxidant activity assessed as AAPH scavenging activity assessed as trolox equivalent after 15 mins measured every min for 90 mins by ORAC-FL method relative to control trolox2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease.
AID667233Cytotoxicity against human MCF7 cells after 96 hrs by SRB assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis and biological evaluation of novel (E) stilbene-based antitumor agents.
AID1238815Cytotoxicity against human HT-29 cells assessed as inhibition of cell growth after 24 hrs by MTT assay2015Journal of medicinal chemistry, Aug-27, Volume: 58, Issue:16
Novel Resveratrol-Based Aspirin Prodrugs: Synthesis, Metabolism, and Anticancer Activity.
AID1083166Antifungal activity against Diplodia seriata assessed as growth inhibition measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID1069497Antiinvasion activity in human MDA-MB-231 cells reduction of cell assessed as inhibition of FBS-induced cell invaded to lower surface at 2 uM after 24 hrs2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Urokinase-type plasminogen activator expression and Rac1/WAVE-2/Arp2/3 pathway are blocked by pterostilbene to suppress cell migration and invasion in MDA-MB-231 cells.
AID1354538Inhibition of PI3K/Akt in mouse J774 cells assessed as reduction in LPS-induced Akt phosphorylation at Ser473 after 4 hrs by Western blot analysis2018Journal of natural products, 05-25, Volume: 81, Issue:5
Natural Stilbenoids Have Anti-Inflammatory Properties in Vivo and Down-Regulate the Production of Inflammatory Mediators NO, IL6, and MCP1 Possibly in a PI3K/Akt-Dependent Manner.
AID1371398Cytotoxicity against human BxPC3 cells assessed as cell viability at 34 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID470661Cytotoxicity against human PANC1 cells in nutrient-deprived condition after 24 hrs by WST8 assay2009Journal of natural products, Sep, Volume: 72, Issue:9
Cytotoxic constituents of Soymida febrifuga from Myanmar.
AID1371466Plasma concentration in mouse at 10 mg/kg, iv at 120 mins by LC-MS/MS method2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1674577Antimicrobial activity against vancomycin-resistant Staphylococcus aureus 510 after 24 hrs by broth microdilution method2020Journal of natural products, 08-28, Volume: 83, Issue:8
Generation of Stilbene Antimicrobials against Multiresistant Strains of
AID1898527Acute toxicity in po dosed ICR mouse assessed as maximum tolerated dose measured after 7 days2021Journal of medicinal chemistry, 06-10, Volume: 64, Issue:11
Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer.
AID1773939Inhibition of NFkappaB activation in LPS-stimulated mouse bone marrow-derived macrophages assessed as reduction in TNFalpha secretion preincubated for 30 mins followed by nigericin addition and measured after 30 mins by ELISA2021Journal of medicinal chemistry, 09-23, Volume: 64, Issue:18
Discovery of Novel Pterostilbene-Based Derivatives as Potent and Orally Active NLRP3 Inflammasome Inhibitors with Inflammatory Activity for Colitis.
AID1674579Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 at 256 ug/ml after 24 hrs by broth microdilution assay2020Journal of natural products, 08-28, Volume: 83, Issue:8
Generation of Stilbene Antimicrobials against Multiresistant Strains of
AID470664Cytotoxicity against human HeLa cells after 72 hrs by MTT assay2009Journal of natural products, Sep, Volume: 72, Issue:9
Cytotoxic constituents of Soymida febrifuga from Myanmar.
AID470663Cytotoxicity against human A549 cells after 72 hrs by MTT assay2009Journal of natural products, Sep, Volume: 72, Issue:9
Cytotoxic constituents of Soymida febrifuga from Myanmar.
AID1069495Antiinvasion activity in human MDA-MB-231 cells reduction of cell assessed as inhibition of FBS-induced cell invaded to lower surface at 10 uM after 24 hrs2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Urokinase-type plasminogen activator expression and Rac1/WAVE-2/Arp2/3 pathway are blocked by pterostilbene to suppress cell migration and invasion in MDA-MB-231 cells.
AID1069492Inhibition of uPA activity in human MDA-MB-231 cells at 5 uM2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Urokinase-type plasminogen activator expression and Rac1/WAVE-2/Arp2/3 pathway are blocked by pterostilbene to suppress cell migration and invasion in MDA-MB-231 cells.
AID1069503Cytotoxicity against human MDA-MB-231 cells assessed as cell viability at 20 uM after 24 hrs by MTT assay relative to control2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Urokinase-type plasminogen activator expression and Rac1/WAVE-2/Arp2/3 pathway are blocked by pterostilbene to suppress cell migration and invasion in MDA-MB-231 cells.
AID1183071Antifungal activity against Candida parapsilosis ATCC 22019 assessed as growth inhibition after 48 hrs by broth microdilution method2014Journal of natural products, Jul-25, Volume: 77, Issue:7
Antifungal activity of resveratrol derivatives against Candida species.
AID1183070Antifungal activity against Candida norvegensis clinical isolate assessed as growth inhibition after 48 hrs by broth microdilution method2014Journal of natural products, Jul-25, Volume: 77, Issue:7
Antifungal activity of resveratrol derivatives against Candida species.
AID1372025Antioxidant activity assessed as relative scavenging rate constant for photolysis-induced hydroxyl radical scavenging activity by measuring Kaox/Kst ratio using DMPO spin trap by ESR spectroscopic method2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Resveratrol analogues like piceatannol are potent antioxidants as quantitatively demonstrated through the high scavenging ability against reactive oxygen species and methyl radical.
AID1371403Cytotoxicity against human LN229 cells assessed as cell viability at 34 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1372027Antioxidant activity assessed as relative scavenging rate constant for photolysis-induced alkoxyl scavenging activity by measuring Kaox/Kst ratio using DMPO spin trap by ESR spectroscopic method2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Resveratrol analogues like piceatannol are potent antioxidants as quantitatively demonstrated through the high scavenging ability against reactive oxygen species and methyl radical.
AID1083165Antifungal activity against Neofusicoccum parvum assessed as growth inhibition measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID1069502Cytotoxicity against human MDA-MB-231 cells assessed as cell viability at 40 uM after 24 hrs by MTT assay relative to control2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Urokinase-type plasminogen activator expression and Rac1/WAVE-2/Arp2/3 pathway are blocked by pterostilbene to suppress cell migration and invasion in MDA-MB-231 cells.
AID1507466Cytotoxicity against human SH-SY5Y cells assessed as cell survival at 500 uM after 24 hrs by MTT assay relative to control2017European journal of medicinal chemistry, Aug-18, Volume: 136Discovery of efficient stimulators for adult hippocampal neurogenesis based on scaffolds in dragon's blood.
AID1272524Agonist activity at rat TRPA1 expressed in HEK293 cells assessed as induction of intracellular calcium level relative to allyl isothiocyanate2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
TRPA1 channels as targets for resveratrol and related stilbenoids.
AID1371374Cytotoxicity against human BxPC3 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1371453Tmax in mouse at 10 mg/kg, iv by LC-MS/MS method2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1371368Cytotoxicity against human MDA-MB-231 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1069499Inhibition of cell migration in human MDA-MB-231 reduction of cell assessed as cells migrated into scratched area at 5 uM after 24 hrs by wound healing assay2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Urokinase-type plasminogen activator expression and Rac1/WAVE-2/Arp2/3 pathway are blocked by pterostilbene to suppress cell migration and invasion in MDA-MB-231 cells.
AID320801Inhibition of beta amyloid 25-35 fibril formation at 10 uM2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
New polyphenols active on beta-amyloid aggregation.
AID82982In vitro inhibitory concentration against proliferation of HL60 cells2003Journal of medicinal chemistry, Jul-31, Volume: 46, Issue:16
Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents.
AID692940Cytotoxicity against human SW480 cells at 10 uM for 2 days by vi-cell cell viability analysis2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
Fluorinated N,N-dialkylaminostilbenes for Wnt pathway inhibition and colon cancer repression.
AID1898526Cytotoxicity against human L02 cells assessed as reduction in cell viability at 32 uM incubated for 48 hrs by MTT assay relative to control2021Journal of medicinal chemistry, 06-10, Volume: 64, Issue:11
Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer.
AID1552788Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS/IFNgamma-induced NO production by measuring NO level preincubated for 2 hrs and followed by LPS/IFNgamma addition and measured after 24 hrs by Griess assay2019Bioorganic & medicinal chemistry letters, 09-01, Volume: 29, Issue:17
Comparative analysis of stilbene and benzofuran neolignan derivatives as acetylcholinesterase inhibitors with neuroprotective and anti-inflammatory activities.
AID1309125Activation of Nrf2 in mouse MIN6 cells assessed as upregulation of human NQO1-ARE-luciferase incubated for 8 hrs by luminometric assay relative to control2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Pterostilbene-mediated Nrf2 activation: Mechanistic insights on Keap1:Nrf2 interface.
AID57709The concentration causing 50% reduction in the net protein increase (cell growth inhibition, GI50) against central nervous system (CNS) SF-268 cells2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin phosphate.
AID1083158Antifungal activity against Diplodia seriata PLU03 assessed as growth inhibition measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID1309128Inhibition of Nrf2-Keap1 (unknown origin) interaction co-expressed in HEK293T cells using D-luciferin as substrate assessed as decrease in luciferase signal intensity at 0.5 to 10 uM by bioluminescence-based IVIS imaging analysis2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Pterostilbene-mediated Nrf2 activation: Mechanistic insights on Keap1:Nrf2 interface.
AID1309124Activation of Nrf2 in mouse MIN6 cells assessed as decrease in cytoplasmic Nrf2 fraction by Western blot analysis2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Pterostilbene-mediated Nrf2 activation: Mechanistic insights on Keap1:Nrf2 interface.
AID1371400Cytotoxicity against human MML1 cells assessed as cell viability at 34 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID370920Inhibition of COX22009Bioorganic & medicinal chemistry, Feb-01, Volume: 17, Issue:3
Synthesis and biological evaluation of a library of resveratrol analogues as inhibitors of COX-1, COX-2 and NF-kappaB.
AID403245Effect on nondiabetic rat assessed as blood glucose level per 100 mL at 20 mg/kg, po1997Journal of natural products, Jun, Volume: 60, Issue:6
Antihyperglycemic activity of phenolics from Pterocarpus marsupium.
AID1069490Inhibition of NF-kappaB activation in human MDA-MB-231 cells after 24 hrs by luciferase assay2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Urokinase-type plasminogen activator expression and Rac1/WAVE-2/Arp2/3 pathway are blocked by pterostilbene to suppress cell migration and invasion in MDA-MB-231 cells.
AID692956Cytotoxicity against human SW480 cells at 10 uM for 4 days by vi-cell cell viability analysis2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
Fluorinated N,N-dialkylaminostilbenes for Wnt pathway inhibition and colon cancer repression.
AID1069500Inhibition of cell migration in human MDA-MB-231 cells reduction of cell assessed as cells migrated into scratched area at 2 uM after 24 hrs by wound healing assay2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Urokinase-type plasminogen activator expression and Rac1/WAVE-2/Arp2/3 pathway are blocked by pterostilbene to suppress cell migration and invasion in MDA-MB-231 cells.
AID1371378Cytotoxicity against human U87 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1371455Plasma concentration in mouse at 10 mg/kg, iv at 60 mins by LC-MS/MS method2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1371379Cytotoxicity against human LN229 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1371392Cytotoxicity against human MDA-MB-231 cells assessed as cell viability at 34 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1272526Antagonist activity at human TRPV1 expressed in HEK293 cells assessed as inhibition of allyl isothiocyanate-induced increase of intracellular calcium level2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
TRPA1 channels as targets for resveratrol and related stilbenoids.
AID667229Cytotoxicity against human A549 cells after 96 hrs by SRB assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis and biological evaluation of novel (E) stilbene-based antitumor agents.
AID82976In vitro concentration required to induce apoptosis in HL60 cells2003Journal of medicinal chemistry, Jul-31, Volume: 46, Issue:16
Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents.
AID1354542Antiinflammatory activity in mouse J774 cells assessed as reduction in LPS-induced MCP1 expression after 24 hrs by ELISA2018Journal of natural products, 05-25, Volume: 81, Issue:5
Natural Stilbenoids Have Anti-Inflammatory Properties in Vivo and Down-Regulate the Production of Inflammatory Mediators NO, IL6, and MCP1 Possibly in a PI3K/Akt-Dependent Manner.
AID1069501Cytotoxicity against human MDA-MB-231 cells assessed as cell viability up to 10 uM after 24 hrs by MTT assay relative to control2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Urokinase-type plasminogen activator expression and Rac1/WAVE-2/Arp2/3 pathway are blocked by pterostilbene to suppress cell migration and invasion in MDA-MB-231 cells.
AID1898495Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2021Journal of medicinal chemistry, 06-10, Volume: 64, Issue:11
Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer.
AID1354546Antiinflammatory activity in carrageenan induced C57BL/6 mouse model of inflammation assessed as reduction in paw edema at 30 mg/kg, ip pretreated for 1 to 2 hrs followed by carrageenan challenge measured after 3 to 6 hrs by plethysmometer2018Journal of natural products, 05-25, Volume: 81, Issue:5
Natural Stilbenoids Have Anti-Inflammatory Properties in Vivo and Down-Regulate the Production of Inflammatory Mediators NO, IL6, and MCP1 Possibly in a PI3K/Akt-Dependent Manner.
AID510868Cytotoxicity against human HT-29 cells after 3 days by [3H]thymidine incorporation assay2010European journal of medicinal chemistry, Sep, Volume: 45, Issue:9
In vitro and in vivo studies on stilbene analogs as potential treatment agents for colon cancer.
AID1371376Cytotoxicity against human MML1 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1083170Antifungal activity against Diplodia seriata assessed as growth inhibition at 500 uM measured after 1 to 10 days relative to control2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID1083159Antifungal activity against Diplodia mutila BRA08 assessed as growth inhibition measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID1773849Cytotoxicity against human L-02 cells incubated for 24 hrs by MTT assay2021Journal of medicinal chemistry, 09-23, Volume: 64, Issue:18
Discovery of Novel Pterostilbene-Based Derivatives as Potent and Orally Active NLRP3 Inflammasome Inhibitors with Inflammatory Activity for Colitis.
AID492062Inhibition of human aromatase preincubated with NADP+ for 10 mins before substrate addition measured after 30 mins2010Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer.
AID692943Cytotoxicity against human LS 174T cells at 10 uM for 4 days by vi-cell cell viability analysis2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
Fluorinated N,N-dialkylaminostilbenes for Wnt pathway inhibition and colon cancer repression.
AID1371369Cytotoxicity against human T47D cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1371401Cytotoxicity against human SK-MEL-2 cells assessed as cell viability at 34 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1847356Oral bioavailability in BALB/c mouse relative to control2021European journal of medicinal chemistry, Nov-05, Volume: 223Recent research and development of NDM-1 inhibitors.
AID1372021Antioxidant activity assessed as Trolox equivalents of photolysis-induced alkoxyl scavenging activity using DMPO spin trap by ESR spectroscopic method2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Resveratrol analogues like piceatannol are potent antioxidants as quantitatively demonstrated through the high scavenging ability against reactive oxygen species and methyl radical.
AID1183067Antifungal activity against Candida kefyr clinical isolate assessed as growth inhibition after 48 hrs by broth microdilution method2014Journal of natural products, Jul-25, Volume: 77, Issue:7
Antifungal activity of resveratrol derivatives against Candida species.
AID370919Inhibition of COX12009Bioorganic & medicinal chemistry, Feb-01, Volume: 17, Issue:3
Synthesis and biological evaluation of a library of resveratrol analogues as inhibitors of COX-1, COX-2 and NF-kappaB.
AID1371399Cytotoxicity against human PANC1 cells assessed as cell viability at 34 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID667226Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis and biological evaluation of novel (E) stilbene-based antitumor agents.
AID1847355Inhibition of NDM-1 (unknown origin) by using nitrocefin as substrate preincubated for 10 min followed by nitrocefin addition incubated after 30 min2021European journal of medicinal chemistry, Nov-05, Volume: 223Recent research and development of NDM-1 inhibitors.
AID614082Antibacterial activity against Enterobacter dissolvens ATCC 222 at 10 mg/ml after 24 to 72 hrs by agar diffusion method2011Bioorganic & medicinal chemistry, Sep-01, Volume: 19, Issue:17
Synthesis and antimicrobial activity of (E) stilbene derivatives.
AID1371377Cytotoxicity against human SK-MEL-2 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1290887Inhibition of rat serum butyrylcholinesterase using butyrylthiocholine iodide substrate after 15 mins by spectrophotometric method2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease.
AID1371461Cytotoxicity against human HT-29 cells assessed as decrease in cell viability at 20 uM after 48 hrs by SRB method relative to control2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1371371Cytotoxicity against human COLO201 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1372023Antioxidant activity assessed as Trolox equivalents of photolysis-induced superoxide anion scavenging activity using CYPMPO spin trap by ESR spectroscopic method2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Resveratrol analogues like piceatannol are potent antioxidants as quantitatively demonstrated through the high scavenging ability against reactive oxygen species and methyl radical.
AID1371459Cytotoxicity against human A375 cells assessed as decrease in cell viability at 20 uM after 48 hrs by SRB method relative to control2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1069487Inhibition of Rac1 in human MDA-MB-231 cells at 5 uM after 30 mins by G-LISA activity assay2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Urokinase-type plasminogen activator expression and Rac1/WAVE-2/Arp2/3 pathway are blocked by pterostilbene to suppress cell migration and invasion in MDA-MB-231 cells.
AID1898497Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2021Journal of medicinal chemistry, 06-10, Volume: 64, Issue:11
Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer.
AID264588Antiproliferative activity against human HL60 cell line2006Journal of medicinal chemistry, May-18, Volume: 49, Issue:10
Identification of a terphenyl derivative that blocks the cell cycle in the G0-G1 phase and induces differentiation in leukemia cells.
AID1256166Inhibition of Quorum sensing system in Chromobacterium violaceum CV026 after 24 hrs by agar-well diffusion method2015Bioorganic & medicinal chemistry letters, Nov-15, Volume: 25, Issue:22
The quorum-sensing inhibiting effects of stilbenoids and their potential structure-activity relationship.
AID1440407Antifungal activity against Candida albicans by broth dilution assay2017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Tackling Fungal Resistance by Biofilm Inhibitors.
AID1372024Antioxidant activity assessed as Trolox equivalents of photolysis-induced singlet oxygen scavenging activity using 4-HO-TEMP spin trap by ESR spectroscopic method2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Resveratrol analogues like piceatannol are potent antioxidants as quantitatively demonstrated through the high scavenging ability against reactive oxygen species and methyl radical.
AID1081915Antifungal activity against Phomopsis obscurans assessed as growth inhibition at 30 uM after 144 hr by NCCLS M27-A broth microdilution method2011Journal of agricultural and food chemistry, Mar-09, Volume: 59, Issue:5
Biological activity of peanut (Arachis hypogaea) phytoalexins and selected natural and synthetic Stilbenoids.
AID1570236Inhibition of human 5-LOX expressed in Escherichia coli BL21 using arachidonic acid as substrate preincubated for 15 mins followed by substrate addition by HPLC analysis2019European journal of medicinal chemistry, Oct-15, Volume: 180Protective effect of piceatannol and bioactive stilbene derivatives against hypoxia-induced toxicity in H9c2 cardiomyocytes and structural elucidation as 5-LOX inhibitors.
AID1083156Antifungal activity against Diplodia seriata LAT28 assessed as growth inhibition measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID1371454Plasma concentration in mouse at 100 mg/kg, po at 60 mins by LC-MS/MS method2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID470665Cytotoxicity against mouse Colon 26-L5 cells after 72 hrs by MTT assay2009Journal of natural products, Sep, Volume: 72, Issue:9
Cytotoxic constituents of Soymida febrifuga from Myanmar.
AID1773851Inhibition of NLRP3 inflammasome activation in LPS-stimulated mouse bone marrow-derived macrophages assessed as reduction in IL-1beta secretion preincubated for 30 mins followed by nigericin addition and measured after 30 mins by ELISA2021Journal of medicinal chemistry, 09-23, Volume: 64, Issue:18
Discovery of Novel Pterostilbene-Based Derivatives as Potent and Orally Active NLRP3 Inflammasome Inhibitors with Inflammatory Activity for Colitis.
AID1183075Antifungal activity against Candida albicans SC5314 ATCC MYA-2876 assessed as inhibition of hyphal formation at 14 ug/ml after 48 hrs by microscopy2014Journal of natural products, Jul-25, Volume: 77, Issue:7
Antifungal activity of resveratrol derivatives against Candida species.
AID1371370Cytotoxicity against human HT-29 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1309127Inhibition of Nrf2-Keap1 (unknown origin) interaction co-expressed in HEK293T cells using D-luciferin as substrate assessed as decrease in luciferase signal intensity incubated for 24 hrs by bioluminescence-based IVIS imaging analysis2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Pterostilbene-mediated Nrf2 activation: Mechanistic insights on Keap1:Nrf2 interface.
AID492060Inhibition of human aromatase at 20 ug/ml preincubated with NADP+ for 10 mins before substrate addition measured after 30 mins2010Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer.
AID264592Antiproliferative activity against human K562 cell line expressing Bcr-Abl2006Journal of medicinal chemistry, May-18, Volume: 49, Issue:10
Identification of a terphenyl derivative that blocks the cell cycle in the G0-G1 phase and induces differentiation in leukemia cells.
AID40024In vitro growth inhibition of BXPC-3 (human pancreatic adenocarcinoma) cell line.2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin phosphate.
AID1069493Down-regulation of uPAR mRNA expression in human MDA-MB-231 cells at 2 to 10 uM after 24 hrs by RT-PCR analysis2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Urokinase-type plasminogen activator expression and Rac1/WAVE-2/Arp2/3 pathway are blocked by pterostilbene to suppress cell migration and invasion in MDA-MB-231 cells.
AID1507467Cytotoxicity against human SH-SY5Y cells assessed as cell survival at 1000 uM after 24 hrs by MTT assay relative to control2017European journal of medicinal chemistry, Aug-18, Volume: 136Discovery of efficient stimulators for adult hippocampal neurogenesis based on scaffolds in dragon's blood.
AID1372029Antioxidant activity assessed as relative scavenging rate constant for photolysis-induced super-oxide anion scavenging activity by measuring Kaox/Kst ratio using CYPMPO spin trap by ESR spectroscopic method2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Resveratrol analogues like piceatannol are potent antioxidants as quantitatively demonstrated through the high scavenging ability against reactive oxygen species and methyl radical.
AID1272522Antagonist activity at rat TRPA1 expressed in HEK293 cells assessed as inhibition of allyl isothiocyanate-induced increase of intracellular calcium level2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
TRPA1 channels as targets for resveratrol and related stilbenoids.
AID1570233Cytoprotective activity against hypoxia-induced toxicity rat H9c2 cells assessed as increase in cell viability at 80 nM preincubated for 18 hrs followed by incubated in hypoxia for 48 hrs by MTT assay2019European journal of medicinal chemistry, Oct-15, Volume: 180Protective effect of piceatannol and bioactive stilbene derivatives against hypoxia-induced toxicity in H9c2 cardiomyocytes and structural elucidation as 5-LOX inhibitors.
AID1083163Antifungal activity against Botryosphaeria dothidea OGE14 assessed as growth inhibition measured after 1 to 10 days relative to control2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID614089Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by sulforhodamine-B colorimetric assay2011Bioorganic & medicinal chemistry, Sep-01, Volume: 19, Issue:17
Synthesis and antimicrobial activity of (E) stilbene derivatives.
AID1898525Cytotoxicity against human MCF-10 A cells assessed as reduction in cell viability at 32 uM incubated for 48 hrs by MTT assay relative to control2021Journal of medicinal chemistry, 06-10, Volume: 64, Issue:11
Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer.
AID1570235Cytoprotective activity against hypoxia-induced apoptosis in rat H9c2 cells assessed as early apoptotic cells at 2 uM preincubated for 18 hrs followed by incubated in hypoxia for 48 hrs by annexin V based flow cytometry (Rvb = 60 %)2019European journal of medicinal chemistry, Oct-15, Volume: 180Protective effect of piceatannol and bioactive stilbene derivatives against hypoxia-induced toxicity in H9c2 cardiomyocytes and structural elucidation as 5-LOX inhibitors.
AID667228Cytotoxicity against human A253 cells after 96 hrs by SRB assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis and biological evaluation of novel (E) stilbene-based antitumor agents.
AID103219Cell growth inhibition of breast MCF-7 cells, expressed as 50% reduction in the net protein increase2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin phosphate.
AID1081919Octanol-water partition coefficient, log P of the compound by HPLC analysis2011Journal of agricultural and food chemistry, Mar-09, Volume: 59, Issue:5
Biological activity of peanut (Arachis hypogaea) phytoalexins and selected natural and synthetic Stilbenoids.
AID1069491Inhibition of uPA activity in human MDA-MB-231 cells at 10 uM2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Urokinase-type plasminogen activator expression and Rac1/WAVE-2/Arp2/3 pathway are blocked by pterostilbene to suppress cell migration and invasion in MDA-MB-231 cells.
AID1083171Antifungal activity against Togninia minima SO21 assessed as susceptibility at 500 uM measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID1372026Antioxidant activity assessed as relative scavenging rate constant for photolysis-induced methyl radical scavenging activity by measuring Kaox/Kst ratio using DMPO spin trap by ESR spectroscopic method2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Resveratrol analogues like piceatannol are potent antioxidants as quantitatively demonstrated through the high scavenging ability against reactive oxygen species and methyl radical.
AID1083152Antifungal activity against Diplodia seriata assessed as mycelium seemed to be halted measured after 2 days environmental scanning electron microscopy2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID1674578Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 after 24 hrs by broth microdilution method2020Journal of natural products, 08-28, Volume: 83, Issue:8
Generation of Stilbene Antimicrobials against Multiresistant Strains of
AID1083161Antifungal activity against Neofusicoccum parvum PER20 assessed as growth inhibition measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID1372020Antioxidant activity assessed as Trolox equivalents of photolysis-induced methyl radical scavenging activity using DMPO spin trap by ESR spectroscopic method2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Resveratrol analogues like piceatannol are potent antioxidants as quantitatively demonstrated through the high scavenging ability against reactive oxygen species and methyl radical.
AID1507472In vivo neurogenic activity in Sprague-Dawley rat neural progenitor cells at 4 mg/kg, ip qd pretreated for 28 days followed by BrdU addition at 2 hrs interval for twice on day 29 measured after 24 hrs by BrdU incorporation assay relative to control2017European journal of medicinal chemistry, Aug-18, Volume: 136Discovery of efficient stimulators for adult hippocampal neurogenesis based on scaffolds in dragon's blood.
AID1371462Cytotoxicity against human MCF7 cells assessed as decrease in cell viability at 20 uM after 48 hrs by SRB method relative to control2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID264590Antiproliferative activity against MDR human HL60R cell line2006Journal of medicinal chemistry, May-18, Volume: 49, Issue:10
Identification of a terphenyl derivative that blocks the cell cycle in the G0-G1 phase and induces differentiation in leukemia cells.
AID1083157Antifungal activity against Lasiodiplodia theobromae CBS116460 assessed as growth inhibition measured after 1 to 10 days2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID770333Inhibition of human quinone reductase 2 expressed in Escherichia coli BL21(DE3) using N-methyldihydronicotinamide as co-substrate2013Bioorganic & medicinal chemistry, Oct-01, Volume: 21, Issue:19
Design, synthesis, biological and structural evaluation of functionalized resveratrol analogues as inhibitors of quinone reductase 2.
AID1070113Allosteric modulation of rat GABAA alpha1beta2gamma2S receptor expressed in Xenopus laevis oocytes assessed as potentiation of GABA-induced chloride ion current at holding potential -70 mV at 100 uM by two-microelectrode voltage clamp assay relative to GA2014Bioorganic & medicinal chemistry, Feb-15, Volume: 22, Issue:4
Identification of dihydrostilbenes in Pholidota chinensis as a new scaffold for GABAA receptor modulators.
AID1069498Inhibition of cell migration in human MDA-MB-231 cells assessed as reduction of cell migrated into scratched area at 10 uM after 24 hrs by wound healing assay2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Urokinase-type plasminogen activator expression and Rac1/WAVE-2/Arp2/3 pathway are blocked by pterostilbene to suppress cell migration and invasion in MDA-MB-231 cells.
AID614080Antibacterial activity against Bacillus brevis ATTC 9999 at 10 mg/ml after 24 to 72 hrs by agar diffusion method2011Bioorganic & medicinal chemistry, Sep-01, Volume: 19, Issue:17
Synthesis and antimicrobial activity of (E) stilbene derivatives.
AID1083169Antifungal activity against Neofusicoccum parvum assessed as growth inhibition at 500 uM measured after 1 to 10 days relative to control2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID1372028Antioxidant activity assessed as relative scavenging rate constant for photolysis-induced peroxyl scavenging activity by measuring Kaox/Kst ratio using CYPMPO spin trap by ESR spectroscopic method2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Resveratrol analogues like piceatannol are potent antioxidants as quantitatively demonstrated through the high scavenging ability against reactive oxygen species and methyl radical.
AID1372030Antioxidant activity assessed as relative scavenging rate constant for photolysis-induced singlet oxygen scavenging activity by measuring Kaox/Kst ratio using 4-HO-TEMP spin trap by ESR spectroscopic method2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Resveratrol analogues like piceatannol are potent antioxidants as quantitatively demonstrated through the high scavenging ability against reactive oxygen species and methyl radical.
AID1704238Antibacterial activity against Methicillin-resistant Staphylococcus aureus ATCC 33591 incubated for 20 hrs by broth two-fold dilution method2020European journal of medicinal chemistry, Nov-15, Volume: 2061,2,3-Triazole-containing hybrids with potential antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA).
AID692942Cytotoxicity against human HCT116 cells at 10 uM for 4 days by vi-cell cell viability analysis2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
Fluorinated N,N-dialkylaminostilbenes for Wnt pathway inhibition and colon cancer repression.
AID1183066Antifungal activity against Candida inconspicua clinical isolate assessed as growth inhibition after 48 hrs by broth microdilution method2014Journal of natural products, Jul-25, Volume: 77, Issue:7
Antifungal activity of resveratrol derivatives against Candida species.
AID1069485Inhibition of Rac1-mediated WAVE-2/Arp2/3 expression in human MDA-MB-231 cells after 24 mins by Western blotting analysis2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Urokinase-type plasminogen activator expression and Rac1/WAVE-2/Arp2/3 pathway are blocked by pterostilbene to suppress cell migration and invasion in MDA-MB-231 cells.
AID1371397Cytotoxicity against human NCI-H460 cells assessed as cell viability at 34 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID667232Cytotoxicity against human Lipo cells after 96 hrs by SRB assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis and biological evaluation of novel (E) stilbene-based antitumor agents.
AID255902Inhibitory concentration required for antiproliferative activity against human MDA-MB-231 cells2005Journal of medicinal chemistry, Nov-03, Volume: 48, Issue:22
Synthesis of a resveratrol analogue with high ceramide-mediated proapoptotic activity on human breast cancer cells.
AID667227Cytotoxicity against human 850C cells after 96 hrs by SRB assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis and biological evaluation of novel (E) stilbene-based antitumor agents.
AID482994Inhibition of amyloid beta 25-35 fibril formation at 10 uM by using UV-visible measurements and electron microscopy analysis2010Bioorganic & medicinal chemistry letters, Jun-01, Volume: 20, Issue:11
New stilbene dimers against amyloid fibril formation.
AID667231Cytotoxicity against human DLD1 cells after 96 hrs by SRB assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis and biological evaluation of novel (E) stilbene-based antitumor agents.
AID1371396Cytotoxicity against human A549 cells assessed as cell viability at 34 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1081911Antifungal activity against Botryotinia fuckeliana assessed as growth inhibition after 72 hr by NCCLS M27-A broth microdilution method2011Journal of agricultural and food chemistry, Mar-09, Volume: 59, Issue:5
Biological activity of peanut (Arachis hypogaea) phytoalexins and selected natural and synthetic Stilbenoids.
AID1371457Tmax in mouse at 100 mg/kg, po by HPLC method2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1371460Cytotoxicity against human A549 cells assessed as decrease in cell viability at 20 uM after 48 hrs by SRB method relative to control2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1372022Antioxidant activity assessed as Trolox equivalents of photolysis-induced peroxyl scavenging activity using CYPMPO spin trap by ESR spectroscopic method2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Resveratrol analogues like piceatannol are potent antioxidants as quantitatively demonstrated through the high scavenging ability against reactive oxygen species and methyl radical.
AID1069494Down-regulation of uPA mRNA expression in human MDA-MB-231 cells after 24 hrs by RT-PCR analysis2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Urokinase-type plasminogen activator expression and Rac1/WAVE-2/Arp2/3 pathway are blocked by pterostilbene to suppress cell migration and invasion in MDA-MB-231 cells.
AID264593Proapoptotic activity against human K562 cell line expressing Bcr-Abl2006Journal of medicinal chemistry, May-18, Volume: 49, Issue:10
Identification of a terphenyl derivative that blocks the cell cycle in the G0-G1 phase and induces differentiation in leukemia cells.
AID403247Decrease in body weight in nondiabetic rat1997Journal of natural products, Jun, Volume: 60, Issue:6
Antihyperglycemic activity of phenolics from Pterocarpus marsupium.
AID1183072Antifungal activity against Candida tropicalis ATCC MYA-3404/T1 assessed as growth inhibition after 48 hrs by broth microdilution method2014Journal of natural products, Jul-25, Volume: 77, Issue:7
Antifungal activity of resveratrol derivatives against Candida species.
AID1704239Bactericidal activity against methicillin-resistant Staphylococcus aureus ATCC 33591 measured after 20 hrs2020European journal of medicinal chemistry, Nov-15, Volume: 2061,2,3-Triazole-containing hybrids with potential antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA).
AID470662Cytotoxicity against human HT1080 cells after 72 hrs by MTT assay2009Journal of natural products, Sep, Volume: 72, Issue:9
Cytotoxic constituents of Soymida febrifuga from Myanmar.
AID94870In vitro growth inhibition of KM20L2 cell line.2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin phosphate.
AID1371394Cytotoxicity against human HT-29 cells assessed as cell viability at 34 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID692941Cytotoxicity against human HCT116 cells at 10 uM for 2 days by vi-cell cell viability analysis2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
Fluorinated N,N-dialkylaminostilbenes for Wnt pathway inhibition and colon cancer repression.
AID146551In vitro growth inhibition of NCI-H460 (human non-small cell lung carcinoma) cell line.2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin phosphate.
AID1371373Cytotoxicity against human NCI-H460 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID667230Cytotoxicity against human A2780 cells after 96 hrs by SRB assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis and biological evaluation of novel (E) stilbene-based antitumor agents.
AID614088Antifungal activity against Botrytis cinerea FSU 883 at 10 mg/ml after 24 to 72 hrs by agar diffusion method2011Bioorganic & medicinal chemistry, Sep-01, Volume: 19, Issue:17
Synthesis and antimicrobial activity of (E) stilbene derivatives.
AID692944Cytotoxicity against human LS 174T cells at 10 uM for 2 days by vi-cell cell viability analysis2011Journal of medicinal chemistry, Mar-10, Volume: 54, Issue:5
Fluorinated N,N-dialkylaminostilbenes for Wnt pathway inhibition and colon cancer repression.
AID1372019Antioxidant activity assessed as Trolox equivalents of photolysis-induced hydroxyl radical scavenging activity using DMPO spin trap by ESR spectroscopic method2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Resveratrol analogues like piceatannol are potent antioxidants as quantitatively demonstrated through the high scavenging ability against reactive oxygen species and methyl radical.
AID1614268Inhibition of human 5-LOX using arachidonic acid as substrate measured after 10 mins by ELISA2019Bioorganic & medicinal chemistry, 02-15, Volume: 27, Issue:4
Design, synthesis and identification of novel coumaperine derivatives for inhibition of human 5-LOX: Antioxidant, pseudoperoxidase and docking studies.
AID1570237Inhibition of 5-LOX in human PMNL cells assessed as A23187-stimulated LTB4 production preincubated for 15 mins followed by A23187 addition and measured after 10 mins by HPLC analysis2019European journal of medicinal chemistry, Oct-15, Volume: 180Protective effect of piceatannol and bioactive stilbene derivatives against hypoxia-induced toxicity in H9c2 cardiomyocytes and structural elucidation as 5-LOX inhibitors.
AID150946In vitro inhibition of P388 (murine leukemia) cell proliferation.2002Journal of medicinal chemistry, Jun-06, Volume: 45, Issue:12
Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin phosphate.
AID1238814Cytotoxicity against human HCT116 cells assessed as inhibition of cell growth after 24 hrs by MTT assay2015Journal of medicinal chemistry, Aug-27, Volume: 58, Issue:16
Novel Resveratrol-Based Aspirin Prodrugs: Synthesis, Metabolism, and Anticancer Activity.
AID1290886Inhibition of Electrophorus electricus acetylcholinesterase using acetylthiocholine iodide substrate after 15 mins by spectrophotometric method2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease.
AID1183069Antifungal activity against Candida lusitaniae CBS 6936 assessed as growth inhibition after 48 hrs by broth microdilution method2014Journal of natural products, Jul-25, Volume: 77, Issue:7
Antifungal activity of resveratrol derivatives against Candida species.
AID1507465Cytotoxicity against human SH-SY5Y cells assessed as cell survival at 100 uM after 24 hrs by MTT assay relative to control2017European journal of medicinal chemistry, Aug-18, Volume: 136Discovery of efficient stimulators for adult hippocampal neurogenesis based on scaffolds in dragon's blood.
AID1083153Antifungal activity against Diplodia seriata assessed as mycelium denser around the initial plug and colonizing measured after 2 days by macroscopic analysis2012Journal of agricultural and food chemistry, Dec-05, Volume: 60, Issue:48
Phenolics and their antifungal role in grapevine wood decay: focus on the Botryosphaeriaceae family.
AID1371393Cytotoxicity against human T47D cells assessed as cell viability at 34 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID667234Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by SRB assay2012European journal of medicinal chemistry, Aug, Volume: 54Synthesis and biological evaluation of novel (E) stilbene-based antitumor agents.
AID1452982Inhibition of recombinant human CYP1A1 expressed in supersomes coexpressing NADPH-CYP reductase using 7-ethoxyresorufin as substrate after 15 mins in presence of NADP+ by Lineweaver-Burk plot analysis2017European journal of medicinal chemistry, Jul-28, Volume: 135Inhibitors of cytochrome P450 (CYP) 1B1.
AID1371402Cytotoxicity against human U87 cells assessed as cell viability at 34 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1452983Inhibition of recombinant human CYP1B1 expressed in supersomes coexpressing NADPH-CYP reductase using 7-ethoxyresorufin as substrate after 15 mins in presence of NADP+ by Lineweaver-Burk plot analysis2017European journal of medicinal chemistry, Jul-28, Volume: 135Inhibitors of cytochrome P450 (CYP) 1B1.
AID1371372Cytotoxicity against human A549 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1354550Antiinflammatory activity in carrageenan induced C57BL/6 mouse model of inflammation assessed as reduction in MCP1 expression in hind paw at 30 mg/kg, ip pretreated for 1 to 2 hrs followed by carrageenan challenge measured after 6 hrs by ELISA2018Journal of natural products, 05-25, Volume: 81, Issue:5
Natural Stilbenoids Have Anti-Inflammatory Properties in Vivo and Down-Regulate the Production of Inflammatory Mediators NO, IL6, and MCP1 Possibly in a PI3K/Akt-Dependent Manner.
AID1371452Cmax in mouse at 10 mg/kg, iv by LC-MS/MS method2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (542)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (0.37)18.2507
2000's37 (6.83)29.6817
2010's329 (60.70)24.3611
2020's174 (32.10)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 41.36

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index41.36 (24.57)
Research Supply Index6.32 (2.92)
Research Growth Index6.48 (4.65)
Search Engine Demand Index119.78 (26.88)
Search Engine Supply Index3.90 (0.95)

This Compound (41.36)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials8 (1.46%)5.53%
Reviews37 (6.74%)6.00%
Case Studies1 (0.18%)4.05%
Observational0 (0.00%)0.25%
Other503 (91.62%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]